Safety alerts
Drug lookup, recalls and shortages
Look up any drug for its FDA label, shortage status and recalls. Below: the recalls that matter most right now, every recall of the last 90 days and every drug in shortage.
New recall alerts
From the last 30 days, often days or weeks before they reach the FDA’s weekly records: the FDA’s own device recall alerts, companies’ recall announcements (drugs, devices, supplements, and foods contaminated with germs or lead), and the USDA’s meat and poultry alerts
-
Sept. 25, 2026FDA alert: most serious device problem
Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters (opens in a new tab)
Boston Scientific Imager II Angiographic Catheters removed due to a manufacturing issue leading to tip detachment; could result in procedural delays, embolism
-
Sept. 24, 2026Food contamination
Galil Importing Corp Recalls Lior Cinnamon Ground Seasoning Due to Elevated Lead Levels (opens in a new tab)
Galil Importing Corp of Hauppauge, New York is recalling Lior Cinnamon Ground Seasoning because it has the potential to be contaminated with elevated levels of lead. Short term exposures to very low levels of lead may not elicit any...
-
Sept. 24, 2026FDA alert: most serious device problem
Heart Pump Controller Recall: Abiomed Removes Automated Impella Controllers (opens in a new tab)
Abiomed is removing Automated Impella Controllers due to purge cassette recognition failures that may lead to prolonged delayed in mechanical circulatory support.
-
Sept. 24, 2026FDA safety notice
Convenience Kit Correction: Becton Dickinson Issues Correction for Kits and Procedure Trays Containing Recalled Sodium Chloride Ampules (opens in a new tab)
BD is correcting convenience kits and procedural trays containing recalled Huons Co. sodium chloride ampules
-
Sept. 23, 2026Food contamination
Berlin Seeds Recalls Alfalfa Sprouting Seed Because of Possible Health Risk (opens in a new tab)
Berlin Seeds, of Millersburg, OH, is recalling 950 lbs of Alfalfa Sprouting Seed because the seed has the potential to be contaminated with Shiga toxin-producing Escherichia coli (STEC) and/or Salmonella.
-
Sept. 23, 2026FDA alert: most serious device problem
Early Alert: Heart Pump Controller Issue from Abiomed (opens in a new tab)
Abiomed is removing certain Impella Controllers with various hardware, firmware, and/or software updates based on a retrospective review of servicing records.
-
Sept. 23, 2026FDA alert: most serious device problem
Early Alert: Ventilator Issue from React Health (opens in a new tab)
IFT cable connector on VOCSN devices may become unseated and lose communication with internal flow transducer board leading to reboots, System Fault 10 Alarms.
-
Sept. 21, 2026Company announcement
Global Mix Inc. Recalls Niwali Tejocote Capsules and Niwali Tejocote Pieces Because of Possible Health Risk (opens in a new tab)
Global Mix Inc. of Middle Village, New York, is recalling niwali Tejocote Capsules (90 capsules, Herbal Supplement) and niwali Tejocote Pieces (90 Day Supply, Herbal Supplement) because FDA analysis has determined that the products appear...
-
Sept. 21, 2026FDA safety notice
Convenience Kit Correction: AVID Medical Issues Correction for Kits Containing Huons Sodium Chloride Ampules (opens in a new tab)
AVID Medical is correcting convenience kits containing recalled Huons Co. sodium chloride ampules.
-
Sept. 21, 2026FDA alert: most serious device problem
Ventilator Recall: CooperSurgical Removes INCA Infant Nasal CPAP Sets (opens in a new tab)
The cannula sets may exhibit a loose connection between the flexible tubing and the nasal cannula resulting in reduced effectiveness and decreased oxygenation.
-
Sept. 18, 2026Company announcementNationwide
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter (opens in a new tab)
ROCHESTER, MI- September 18, 2026 -Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product is being recalled due to the presence of...
-
Sept. 18, 2026FDA alert: most serious device problem
Sodium Chloride Flush Recall: Spectra Medical Removes Sodium Chloride Injection USP Ampules (opens in a new tab)
Spectra Medical Devices is removing Sodium Chloride Flush products that were manufactured by Huons Co,. Ltd.
-
Sept. 18, 2026FDA safety notice
Nitric Oxide Delivery System Correction: NOxBOX Updates Use Instructions for NOxBOXi Nitric Oxide Delivery System (opens in a new tab)
The NOxBOX NOxBOXi System may leak oxygen during inhaled nitric oxide therapy
-
Sept. 17, 2026Company announcementNationwide
Otsuka ICU Medical LLC Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection, USP Due To a Product Mix-up with 10 mEq Potassium Chloride Injection (opens in a new tab)
Otsuka ICU Medical LLC is issuing a voluntary recall for one lot of 0.9% SODIUM CHLORIDE Injection, USP, 100mL single pack to the user level due to a potential mix-up. The affected lot of 0.9% SODIUM CHLORIDE Injection, USP (NDC...
-
Sept. 15, 2026Food contamination
Gias Foods, Inc. Recalls Bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Risk (opens in a new tab)
Gias Foods of New York, NY is recalling 2 Lots of bettergoods Authentic Italian Lemon Alfredo Fettuccine, because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal...
-
Sept. 15, 2026FDA alert: most serious device problem
Esophageal pH Monitoring Capsule Recall: Medtronic and Given Imaging Remove Esophageal pH Monitoring Capsule Delivery Device (opens in a new tab)
The Medtronic and Given Imaging Bravo CF esophageal pH monitoring capsule can fail to attach to the esophagus or detach from its delivery device.
-
Sept. 14, 2026Company announcementNationwide
A&P Creations LLC Issues Nationwide Recall of biQ-FEL Due to Undeclared Sildenafil and Tadalafil (opens in a new tab)
Sildenafil and Tadalafil are active ingredients in FDA-approved prescription drugs Viagra and Cialis, respectively, used to treat erectile dysfunction. FDA approval of Viagra and Cialis is restricted to use under the supervision of a...
-
Sept. 14, 2026Company announcementNationwide
A&P Creations LLC Issues Nationwide Recall of X10 Natural Enhancement Supplement Due to Undeclared Sildenafil and Tadalafil (opens in a new tab)
Clermont, Florida, A&P Creations LLC is recalling X10 Natural Enhancement Supplement to the consumer level because it has been found to contain undeclared sildenafil and tadalafil.
-
Sept. 11, 2026Company announcementNationwide
Centric Compounding Issues Nationwide Recall of Glutathione, Myer’s Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels (opens in a new tab)
FOR IMMEDIATE RELEASE, 9/9/2026, Houston, Texas, Centric Compounding is voluntarily recalling 6 lots of Glutathione 200mg/mL, Myer’s Cocktail, and Tri-Immune Boost injectable vials to the consumer level. The products have been found to be...
-
Sept. 10, 2026Food contamination
Evergreen Fresh Sprouts LLC Recalls Broccoli Sprouts Because of Possible Health Risk (opens in a new tab)
09/10/2026, Evergreen Fresh Sprouts LLC of Moyie Springs, IDAHO is recalling 215 cases (6/4oz bags per case) of Broccoli Sprouts, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and...
-
Sept. 10, 2026FDA safety notice
Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules (opens in a new tab)
Medical Action Industries is correcting epidural kits containing recalled Huons Co. sodium chloride ampules.
-
Sept. 7, 2026Company announcement
BMC Medical Co., Ltd. Recalls Luna G3 APAP (Model LG3600) with Firmware G3-2.00.76 Due to Firmware Defect (opens in a new tab)
On July 15, 2026, BMC Medical Co., Ltd. (BMC), Beijing, China, retrospectively reported to the US Food and Drug Administration (FDA) a recall of 20,160 Luna G3 APAP (Model LG3600) devices distributed in the United States due to firmware...
-
Sept. 6, 2026Food contamination
Made Fresh Salads, Inc. Recalls Ready to Eat Deli Style Salads and Cream Cheese Because of Possible Health Risk (opens in a new tab)
Made Fresh Salads Inc. of Bay Shore, NY is recalling all Ready to Eat Deli Style Salads and cream cheese, because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes...
-
Sept. 6, 2026USDA meat and poultry alert
Prime Line Distributors, Inc. and Ferrarini USA, Inc. Recall Imported Ready-To-Eat Pork Guanciale Products Due to Possible Listeria Contamination (opens in a new tab)
Prime Line Distributors, Inc., a Fort Lauderdale, Fla., firm, and Ferrarini USA, Inc., a Hoboken, N.J., firm, are recalling approximately 1,513 pounds of imported ready-to-eat (RTE) pork products that may be adulterated with Listeria...
-
Sept. 4, 2026Food contamination
Foods Alive Inc. recalls Moringa Leaf Powder (opens in a new tab)
Potential to be contaminated with Salmonella
-
Sept. 4, 2026Company announcement
SUPPLX.com recalls dietary supplements marketed for male sexual enhancement (Business Pill, Branch Manager for Men) (opens in a new tab)
Products contain undeclared yohimbine
-
Sept. 3, 2026Company announcementNationwide
B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter (opens in a new tab)
FOR IMMEDIATE RELEASE, September 3, 2026- Bethlehem, PA, B. Braun Medical Inc (B. Braun) is voluntarily recalling three (3) lots of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container, to the hospital/healthcare...
-
Sept. 3, 2026FDA alert: most serious device problem
Spinal Cord Stimulator Recall: Boston Scientific Removes Infinion CX Lead (opens in a new tab)
Infinion CX Lead bodies may experience mechanical stress at the anchor site resulting in inadequate stimulation requiring lead explant and replacement.
-
Sept. 3, 2026FDA alert: most serious device problem
Early Alert: Breathing Circuit Issue from Draeger (opens in a new tab)
Removal of VentStar Resus Neo hoses due to the potential for cracks resulting in restricted ventilation or delayed therapy.
-
Sept. 3, 2026FDA safety notice
Monitoring System Correction: GE HealthCare Updates Use Instructions for Portrait Core Services Software (opens in a new tab)
Patients monitored on Portrait Mobile devices may be discharged (removed) from the Portrait monitoring system during an update to the Portrait Core Services software.
-
Sept. 3, 2026Company announcement
American Regent, Inc. recalls Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vial (opens in a new tab)
Presence of particulate matter and lack of sterility assurance
-
Sept. 3, 2026Food contamination
Frutas y Hortalizas del Sur S.A. recalls Organic Triple Berry Blend (Great Value) (opens in a new tab)
Possible E. Coli Contamination
-
Sept. 2, 2026FDA alert: most serious device problem
Catheter Recall Expansion: Medline Industries Removes Reprocessed Electrophysiology and Ultrasound Catheters (opens in a new tab)
Certain reprocessed catheters may contain residual particulates that could cause infection, embolism, or thrombosis
-
Sept. 2, 2026FDA safety notice
Convenience Kit Correction: Medline Issues Correction for Convenience Kits Containing BD ChloraPrep Applicators (opens in a new tab)
Certain BD ChloraPrep Applicators in Convenience Kits manufactured by Medline may not be sterile.
-
Aug. 31, 2026Company announcement
Ana Salazar Modela Tu Cuerpo Inc. recalls Lipofit Extreme 2.0 Fat Burner Dietary Supplement (opens in a new tab)
Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
-
Aug. 29, 2026Food contamination
Panorama Produce recalls Mangoes (Martina) (opens in a new tab)
Potential contamination with Salmonella
-
Aug. 29, 2026Food contamination
Everything Sprouts, LLC recalls Robust Radish Mix, 5oz Cups (opens in a new tab)
Potential to be contaminated with Shiga toxin-producing Escherichia coli (STEC) or Salmonella.
Recalls to know about
From the FDA’s recall records, with its newest postings as of Sept. 26 at 3:06 PM CT. Ranked by seriousness, how widely the drug is used, reach and recency
-
Sept. 2, 2026
Drug recall, ongoing
Levothyroxine Sodium (12 products)
Accord Healthcare, sold nationwide
Why: Subpotent Drug
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Semaglutide (11 products)
Apollo Care, sold nationwide
Why: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Drug recall, ongoing
Thyroid Tablets
Vitruvias Therapeutics
Why: Superpotent Drug
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride
B Braun Medical, sold nationwide
Why: Presence of Particulate matter.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Levothyroxine Sodium (12 products)
Major Pharmaceuticals, sold nationwide
Why: Subpotent Drug
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Clindamycin Phosphate and Vasopressin in 0.9% Sodium Chloride and 8 more (17 products)
Baxter Healthcare, sold nationwide
Why: CGMP Deviations
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Cetirizine Hydrochloride
Jb Chemicals and Pharmaceuticals, sold nationwide
Why: Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Bravo Cf Capsule Delivery Device
Given Imaging, sold nationwide
Why: Capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab)
All recalls, last 90 days
513 recalls, newest first
-
Sept. 25, 2026
Device recall, ongoing
Computed Tomography X-Ray System and Positron Emission Tomography and Computed Tomography System (12 items)
Shanghai United Imaging Healthcare Co.
Why: Positron emission tomography and computed tomography x-ray systems have a software problem when Split or Local function is enabled, and multiple RIS exams are merged into a single study, that prevents patient images...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Mr and Smartpath To Dstream for and 4 more (7 items)
Philips North America
Why: When exporting diffusion tensor imaging (DTI) scans from a MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Biologic recall, ongoing
Apheresis Platelets
Lifesouth Community Blood Centers
Why: Leukoreduced Apheresis Platelets product, for which platelet yield did not meet specifications, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Biologic recall, ongoing
Apheresis Platelets (2 items)
Lifesouth Community Blood Centers
Why: Leukoreduced Apheresis Platelets product, for which platelet yield did not meet specifications, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Biologic recall, ongoing
Apheresis Platelets (2 items)
Lifesouth Community Blood Centers
Why: Leukoreduced Apheresis Platelets product, for which platelet yield did not meet specifications, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Biologic recall, ongoing
Apheresis Platelets
Lifesouth Community Blood Centers
Why: Apheresis Platelets, Leukocytes Reduced, Irradiated product, for which platelet yield did not meet specifications, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Biologic recall, ongoing
Apheresis Platelets
Lifesouth Community Blood Centers - Montgomery Region
Why: Apheresis Platelets, Leukocytes Reduced, Irradiated product, for which platelet yield did not meet specifications, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Biologic recall, ongoing
Cornea
Eversight Illinois
Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Biologic recall, ongoing
Cornea
Visiongift
Why: Cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Mckesson Consult Hcg Urine Cassette and Fisher Scientific Sure-Vue Serum/Urine Hcg and 2 more (4 items)
Alere San Diego
Why: hCG rapid tests may detect low levels of hCG below the stated assay sensitivity, which may result in false positive result.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Embosphere
Merit Medical Systems
Why: Microspheres used in embolization of tumors, prostatic arteries, arteriovenous malformations, and blood vessels may have holes in packaging that may affect the sterile barrier, which if used could lead to infection.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Encor Encompass Breast Biopsy and Tissue Removal System Console
Bard Peripheral Vascular
Why: Breast biopsy and tissue removal system may experience the following errors: 1) Probe calibration and /or handheld driver failure (code HH01-00020009) , 2) Pressure sensor (code E01-0054000E), which prompts the user to...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Palacos R Pro and Palacos R+G Pro and 2 more (4 items)
Heraeus Medical Gmbh (Dental Division)
Why: Potential for monomer liquid leakage.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Philips Intrasight Plus Ref:
Volcano
Why: Software system may associate image data from one patient with another patient's record, potentially resulting in incorrect diagnosis or treatment.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Performance Pro and Opportunity Flex and 1 more (3 items)
American Nitrile Operations
Why: Gloves may exhibit defects such as tears, missing fingers, and debris. Use of defective gloves may lead to healthcare personnel and patient exposure to infectious pathogens leading to infection or cross-contamination...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Medical Convenience Kits Containing Bd Cliniclean Pericare Wipes Within Bd Urina (3 items)
American Contract Systems
Why: Kits contain manufacturer-recalled perineal care (pericare) wipes within urinary catheter trays, which may be contaminated with a lubricant used during the manufacturing process. Use of a contaminated wipe may lead to...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Presource Packs Containing Stryker Strykeflow Ps and Ahto Tube Sets: 1) Kit (4 items)
Cardinal Health 200
Why: The kits contain tube sets with handpieces that may leak during use. The impacted devices can have the following failures: fluid leakage from the hand piece that can pool on the floor. The impact can range from user...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Olympus M3 Gold Autoclavable Foroblique Telescope and Olympus M3 Gold Autoclavable Lateral Telescope (2 items)
Olympus Corporation of the Americas
Why: There are identified discrepancies between the sterilization parameters listed in the Instructions for Use and the sterilization parameters listed in the Japanese package insert.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Noxboxi Nitric Oxide Delivery System. Model Number: Noxbox-I.
Noxbox
Why: Potential for irregular oxygen readings due to a manufacturing issue affecting certain oxygen sensors.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Ingenia Blue Seal Se and Blue Seal Xe and Ingenia and 1 more (4 items)
Philips North America
Why: When exporting diffusion tensor imaging (DTI) scans from a MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Ingenia Elition S and Ingenia Elition X.
Philips North America
Why: When exporting diffusion tensor imaging (DTI) scans from a MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Drug recall, ongoing
Ranolazine Extended-Release Tablets
Ajanta Pharma USA
Why: Failed Dissolution Specifications
Not Yet Classified
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Biologic recall, ongoing
Cornea
Saving Sight
Why: Corneas, recovered from donors whose donor eligibility was not determined by using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately...
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 25, 2026
Device recall, ongoing
Heartsine Samaritan Pad
Heartsine Technologies
Why: Products were distributed without the required Maintenance Supplement, which describes an extra check every 3 months in addition to the monthly check.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Device recall, ongoing
Medline Convenience Kits: 1) Peds Sinus Pack and Medline Convenience Kits: 1) Major Pack and 3 more (5 items)
Medline Industries
Why: The kits contain neurological sponges with the potential for unexpected variability of endotoxin levels. Potentially elevated endotoxin levels may present health risks that could require medical intervention, such as...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Food recall, ongoing
Lemon Alfredo Fettuccine Packed in A Yellow Plastic Sealed Bag with Pink and Bla
Gias Food
Why: Contamination with Listeria monocytogenes
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Biologic recall, ongoing
Red Blood Cells
Hcsc-Blood Center
Why: Red Blood Cells, Leukocytes Reduced, Irradiated, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Biologic recall, ongoing
Red Blood Cells
Hcsc-Blood Center
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Biologic recall, ongoing
Pf24 Plasma
Hcsc-Blood Center
Why: PF24 Plasma, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Biologic recall, ongoing
Apheresis Red Blood Cells
Oneblood
Why: Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Biologic recall, ongoing
Red Blood Cells
Lifestream Blood Bank
Why: Leukoreduced Red Blood Cells product, which was labeled as leukocytes reduced but was not tested to verify white blood cell count, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Biologic recall, ongoing
Apheresis Platelets
West Tn Regional Blood Center
Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were not tested for pH, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Biologic recall, ongoing
Apheresis Platelets
New York Blood Center
Why: Leukoreduced Apheresis Platelets products, with a platelet count higher than was acceptable, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Device recall, ongoing
Pro+ Mrs Surface for Versacare and Pro+ (3 items)
Baxter Healthcare
Why: There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 24, 2026
Biologic recall, ongoing
Red Blood Cells
Blood Assurance
Why: Leukoreduced Red Blood Cells product, not labeled with a tag indicating that it contained antibodies, was distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Imager Ii Angiographic Catheters M001314001 Imager Ii/5/St/65/038 Bx5
Boston Scientific
Why: Tip may fracture or detach, leading to device fragments remaining within the patient or migrating through the vasculature. Patient impact may include prolonged procedure or life-threatening embolism.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Halyard IV Start Kit Non-Sterile
Avid Medical
Why: Convenience kits containing BD ChloraPrep Clear - 1 mL Applicator, which may be contaminated with Aspergillus penicillioides.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Biologic recall, ongoing
Red Blood Cells
Hcsc-Blood Center
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Biologic recall, ongoing
Red Blood Cells
Hcsc-Blood Center
Why: Red Blood Cells, Leukocytes Reduced, Irradiated, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Biologic recall, ongoing
Pf24 Plasma
Hcsc-Blood Center
Why: PF24 Plasma, collected from a donor for whom donor eligibility screening was incomplete, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Volara
Baxter Healthcare
Why: Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to firm and testing confirmed devices meet specifications.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Cardioroot Woven Collagen Coated Vascular Graft
Intervascular, Sas
Why: Product failed to meet the specified acceptance criteria for Integral Water Permeability (IWP).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
New York Embroidery Studio Trinity Non-Surgical Isolation Gown
New York Embroidery Studio
Why: Gowns do not consistently meet the minimum liquid-barrier performance required.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Device recall, ongoing
Halyard IV Start Kit Non-Sterile (2 items)
Avid Medical
Why: Convenience kits containing BD ChloraPrep Clear - 1 mL Applicator, which may exhibit an open or incomplete seal on the packaging of the applicator.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Drug recall, ongoing
Clear Eyes Redness Relief (2 products)
Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 23, 2026
Drug recall, ongoing
0.9% Sodium Chloride Injection
Otsuka Icu Medical
Why: Product Mix-up: 0.9% SODIUM CHLORIDE Injection, USP may potentially contain the overwrap with labeling indicating it to be 0.9% SODIUM CHLORIDE Injection, USP but the actual product within the overwrap may be POTASSIUM...
Not Yet Classified
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Pooled Cryoprecipitated Ahf
Impactlife
Why: Pooled Cryoprecipitated AHF, not prepared in accordance with specifications, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Red Blood Cells
the Blood Connection
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who had taken the drug Accutane, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Red Blood Cells
the Blood Connection
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor currently taking Proscar, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Red Blood Cells
the National American Red Cross
Why: Red Blood Cells, Leukocytes Reduced, which were labeled as antigen negative, but were collected from a donor who subsequently tested antigen positive, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Red Blood Cells
American National Red Cross (the), Lewis and Clark Region
Why: Misbranded Red Blood Cells, Leukocytes Reduced, Irradiated, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Red Blood Cells
Penn State Health Holy Spirit Medical Center
Why: Red Blood Cells, Leukocytes Reduced, with incomplete testing, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Bone
Tissue Transplant Technology
Why: Bone products, processed in a manner that could cause contamination, cross-contamination, or the introduction, transmission, or spread of communicable disease, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Cornea
Lions Eye Bank of Nebraska
Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Cornea
San Antonio Eye Bank
Why: Mislabeled cornea was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Cornea
Onelegacy
Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Cornea
Eversight Illinois
Why: Cornea, recovered from a donor in which donor eligibility was not adequately determined, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Cornea
Onelegacy
Why: Corneas, recovered from donors in which donor eligibility was not adequately determined, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Device recall, ongoing
Ngenuity Patient Monitor with Capnography
Criticare Technologies
Why: Complaint trend where "Checkline Error" alarm presents at device setup, rendering the CO2 monitoring function inoperable. May result in procedure delay.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Device recall, ongoing
Presource Convenience Kits: 1) Kit (2 items)
Cardinal Health 200
Why: The kits contain applicators that may exhibit an open or incomplete seal on the packaging of the applicator. Use of a potentially contaminated applicator could result in no patient harm or may lead to localized skin or...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Device recall, ongoing
Ref:
Deroyal Industries
Why: Myocardial temperature probes contain an incorrect needle. Specifically, an 18mm needle was included instead of a 15mm needle.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Drug recall, ongoing
Exenatide Injection
Amneal Pharmaceuticals of New York
Why: Defective Delivery System: Possibility of no medication in the prefilled pen.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Red Blood Cells
Carter Bloodcare
Why: Red Blood Cells, Leukocytes Reduced, which were leukoreduced by filtration at an unacceptable temperature, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Apheresis Platelets
the American National Red Cross South Carolina Region
Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were out of monitored storage for an extended period of time, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Red Blood Cells
the American National Red Cross South Carolina Region
Why: Red Blood Cells, Leukocytes Reduced, which were out of monitored storage for an extended period of time, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Biologic recall, ongoing
Cornea
South Dakota Lions Eye Bank
Why: Corneas, recovered from a donor who was not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 22, 2026
Drug recall, ongoing
Olanzapine Tablets
Macleods Pharmaceuticals Limited
Why: Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Drug recall, ongoing
Avkare Carboxymethylcellulose Sodium Ophthalmic Solution and Reliable -1 Laboratories and 6 more (9 products)
Sterling Pharmaceutical Services
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Cornea
Eversight Illinois
Why: Cornea, processed without conducting the proper antibiotic soak, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Apheresis Platelets
Lifesouth Community Blood Centers
Why: Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced product, for which platelet yield did not meet specifications, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Red Blood Cells
Mississippi Blood Services
Why: Red Blood Cells, Leukocytes Reduced, collected from an unsuitable donor due to a donor screening deviation, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Red Blood Cells
Mississippi Blood Services
Why: Leukoreduced Red Blood Cells products, collected from a donor with hemoglobin lower than was acceptable, or who had no hemoglobin check performed during screening, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Red Blood Cells
Department of Defense - Air Force
Why: Red Blood Cells product, collected from a donor who previously tested repeatedly reactive for the antibody to Human T-Lymphotropic Virus (HTLV-I), was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Red Blood Cells
the Blood Center
Why: Red Blood Cells, Leukocytes Reduced, incorrectly labeled as irradiated, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Red Blood Cells
Vitalant
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who provided travel history to a malaria endemic area, but was not assessed for residency, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Apheresis Platelets
the American National Red Cross
Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were not tested for pH or platelet yield, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Whole Blood
Department of Defense - Navy
Why: Whole Blood, which tested negative for the antibody to the Human T-Lymphotropic Virus (Anti-HTLV) but was collected from a donor who previously tested repeatedly reactive for anti-HTLV, Western blot positive, was...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Red Blood Cells
Arup Laboratories
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor taking an unlicensed, unapproved, or experimental medication, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Cornea
Corneagen - Boston
Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Cornea (2 items)
Precision Ocular Network - Bartlett
Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Cornea
Eversight
Why: Cornea, recovered from a donor in which donor eligibility was not adequately determined, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Cornea
Rocky Mountain Lions Eye Bank
Why: Corneas, recovered from donors in which donor eligibility was not adequately determined, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Cornea
Onelegacy
Why: Corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Cornea
Corneagen - Boston
Why: Corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Cornea
Iowa Lions Eye Bank
Why: Corneas, processed using an expired viewing chamber, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Device recall, ongoing
Foresight Elite Tissue Oximetry Cable Ref Hemfsm10 Udi-Di Code:
Becton, Dickinson and
Why: Due to incorrect switching of Channel 1 and 2 on the module and flag labels on the tissue oximetry cables.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Device recall, ongoing
Automated Impella Controller
Abiomed
Why: Retrospective report of issues remedied in 2019 with firmware and software patches: 1. Defects in optical bench (OPB) firmware V2.19, which affected the accuracy and stability of the pressure signal the AIC system...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Apheresis Platelets
Hcsc-Blood Center
Why: Apheresis Platelets, Leukocytes Reduced, which were exposed to unacceptable storage temperatures, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 21, 2026
Biologic recall, ongoing
Cornea
Eversight Illinois
Why: Corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Inca (2 items)
Coopersurgical
Why: Potential to exhibit a loose connection between the flexible tubing and the nasal cannula, during assembly or while in use, which may result in loss of CPAP pressure, possibly reducing the effectiveness of treatment and...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Achieva and Achieva XR and 7 more (12 items)
Philips North America
Why: A software issue will terminate an examination during the image reconstruction process if the scan parameters are manually adjusted such that reconstruction requirements exceed the available system memory.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Food recall, ongoing
Evergreen Fresh Sprouts LLC
Evergreen Fresh Sprouts
Why: Salmonella
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Spectralis with Flex Module
Heidelberg Engineering Gmbh
Why: Wheels may come loose when module is being pushed or pulled during movement or transportation, affecting stability of the stand. The stand may tip over as a result. Falling stand may cause impact or crushing injuries...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Olympus Bicoag Hemostasis Probe (4 items)
Olympus Corporation of the Americas
Why: Potential for detachment of ceramic tip due to manufacturing without the designated amount of adhesive.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Olympus Ezdilate Endoscopic Balloon Dilator Wired-Guided
Olympus Corporation of the Americas
Why: Potential for the inflation chart label affixed to the shaft of the device to be incorrect and indicate a balloon diameter of 18, 19, or 20 mm,
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Midmark Iqvitals Zone (4 items)
Midmark
Why: A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Hf2p0st9 Homefill Oxygen System Homefill Cylinder M9 with Cga870 Compatible Post and Ref:Hf2pc9 Homefill Oxygen System and 1 more (3 items)
Ventec Life Systems
Why: Labeling; Oxygen Cylinders do not contain required medical gas labeling
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Extended Polyaxial Head
Seaspine Orthopedics
Why: The proximal thread depth of the spinal device is out of design specification.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Powerled
Maquet Sas
Why: The potential for the device to detach at the junction between the spring arm and suspension arm and fall causing potential injury.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Combiset Hemodialysis Blood Tubing Set with Attached Priming Set and Transducer
Fresenius Medical Care Renal Therapies Group
Why: Communication to recommend reviewing the IFU and ensuring that all treatment preparation and handling steps are performed as instructed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Philips Epiq Elite Diagnostic Ultrasound System Model #
Philips Ultrasound
Why: Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Medline Convenience Kits Containing Healthmark Instrument Channel Brushes. Sinus and Medline Convenience Kits Containing Healthmark Instrument Channel Brushes. Sinus (2 items)
Medline Industries
Why: Kits contain Healthmark Instrument Channel Brushes, which were recalled by the manufacturer due to the potential for a sharp edge/burr on the end of the brush. Potential hazards associated include cut injury/abrasion...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Vitek
Biomerieux
Why: The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Device recall, ongoing
Coopervision
Why: A small number of lenses within the affected lot are of the incorrect power.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Drug recall, ongoing
Menow Sunscreen Pressed Powder Spf35 Pa+++
Shantou Qiwei Industrial Co.
Why: cGMP Deviations
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 18, 2026
Food recall, ongoing
Pecorino Toscano D.O.P. Stagionato Cheese Wheels. Product of Italy. Each Cheese
Elegant Foods
Why: Potential Listeria contamination from dripping condensation in cooler.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 17, 2026
Food recall, ongoing
Mon Sire Brie
Optimus Inc. D/B/A/ Markys Caviar
Why: The firm was notified by their Brie Cheese supplier that sample results revealed the presence of Listeria monocytogenes.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 17, 2026
Device recall, ongoing
Reign Medical Clench Staple System
F & A Foundation
Why: Bone fixation staple requires a new 510(k); the performance characteristics of this device have not been adequately established.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 17, 2026
Device recall, ongoing
Cadd Yellow Medication Cassette Reservoir with Nrfit Connector US Product Codes:
Icu Medical
Why: Reservoirs may exhibit medication leakage at the joint between luer connector and tubing. Issue could result in delay or interruption of therapy, under delivery of medication, exposure to infectious or toxic agents, or...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 17, 2026
Device recall, ongoing
Pi-Cardia Inc. Shortcut Ref: Z-A-20.003-US
Pi Cardia
Why: Transfemoral catheter, positing arm may detached due to weld issue.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 17, 2026
Drug recall, ongoing
Dopamine HCL Inj.
Pfizer
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Bravo Cf Capsule Delivery Device
Given Imaging, sold nationwide
Why: Capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Dextrose Injection
Baxter Healthcare, sold nationwide
Why: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Products That Contain the Pericare Wipes: Surestep" Foley Tray System Add-A-Fol and Products That Contain the Pericare Wipes: Bard¿ Foley Tray with Lubri-Sil¿ All- and 4 more (6 items)
C.R. Bard, sold nationwide
Why: Due to complaints received indicating presence of contamination on the surface of pericare wipes provided with various Foley and Intermittent Catheter Trays.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Kit: Single Shot Epidural and Kit: Epidural/Pain Tqc (2 items)
Medical Action Industries, Inc. 306
Why: Kits containing Sodium Chloride ampules subject to another recall are recalled due to potentially compromised sterility.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Automated Impella Controller and Impella Optical Controller with the Below Product Descriptions and Corresponding and 1 more (3 items)
Abiomed
Why: The potential for purge cassette recognition issues due to the failure of the purge flag component of the purge pressure sensor assembly.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Haylard and Haylard Continuous Nerve Block Tray and 2 more (4 items)
Avid Medical
Why: Potential for product quality and sterility issues regarding kits containing Sodium Chloride ampules subject to recall by Spectra Medical.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Medicalyte Liquid Bicarbonate Concentrate Ref: Bc-100 and Bc+201 and Citric Complete Liquid Citric Acid Concentrate Ref: Lc+200-D and 2 more (4 items)
Nipro Renal Soultions USA, sold nationwide
Why: Hemodialysis concentrates contain high endotoxin levels
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Heartsine Sam
Heartsine Technologies, sold nationwide
Why: Due to a damaged (over stretched) membrane tail that causes an intermittent fault.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Food recall, ongoing
Pico De Gallo-Mild-4oz Pico De Gallo-Mild-6/14oz Pico De Gallo-4/5# Pico De Gall and Soup Mix-6/58oz Tray and 6 more (8 items)
Naturebest Pre-Cut & Produce
Why: Jalapenos have the potential to be contaminated with Salmonella
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Fluphenazine Hydrochloride
Ajanta Pharma USA, sold nationwide
Why: Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Dermav Laser System
Lutronic, sold nationwide
Why: Utilizing higher fluences at 1064nm wavelength with current cryogen parameters may result in a spark/loud noise during treatment, potentially resulting in patient burn.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Getinge Pvc Thoracic Catheter (3 items)
Atrium Medical, sold nationwide
Why: An Out of Specification result (OOS) related to bacterial endotoxin testing in a single lot of catheters.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Ams Convenience Kit: Dsaek Pack - Rx
Windstone Medical Packaging, sold nationwide
Why: The convenience kits contain .0.9% Sodium Chloride Injection, USP products in Single Dose freeflex bags, which may contain blue Break-off-Parts (BOPs) that have detached from the infusion port during manipulation.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Halyard IV Start Kit Non-Sterile Ref: Kriv26-02
Avid Medical, sold nationwide
Why: Convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which lacks sterility assurance due to to wrinkles in the paper lidding which may breach the seal area.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Axle Pin Assy Large Elbow Cobalt Chrome Catalog No. C-M112-2-500 Orthopaedic Imp and Omnifit Series I Acet. Insert and 10 more (12 items)
Howmedica Osteonics
Why: Affected devices were manufactured with Ultra High Molecular Weight Polyethylene (UHMWPE) raw material aged in excess of five years. Product has the potential for elevated levels of oxidation, which may result in...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Ref:2b5lt Ethicon Endo-Surgery and Ref:2b5st Ethicon Endo-Surgery and 4 more (6 items)
Stryker Sustainability Solutions
Why: Reusable access port system may crack or seperate during use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Food recall, ongoing
Organic Triple Berry Blend Strawberries
Frutas Y Hortalizas Del Sur S.A.
Why: Potential E. coli O145:H28 Contamination
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Fentanyl Citrate
Ourpharma, sold nationwide
Why: Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).
Not Yet Classified
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Biologic recall, ongoing
Red Blood Cells
American National Red Cross (the)
Why: Red Blood Cells, Leukocytes Reduced, Irradiated, collected in a manner that compromises the sterility of the collection system, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Biologic recall, ongoing
Pf24 Plasma
American National Red Cross (the)
Why: PF24 Plasma, collected in a manner that compromises the sterility of the collection system, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Biologic recall, ongoing
Red Blood Cells
American National Red Cross (the)
Why: Red Blood Cells, Leukocytes Reduced, collected in a manner that compromises the sterility of the collection system, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Hemospray Endoscopic Hemostat
Wilson-Cook Medical
Why: Due to issue with endoscope adherence and inability to spray powder. Firm will provide an updated Instruction for Use (IFU).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Kinos Axiom Total Ankle System with Axiom Psr
Restor3d
Why: Ankle implantation systems were packaged with incorrect patient-specific cutting guides, which may result in: delayed surgery, the need to use standard instrumentation, reduced fixation or poor alignment of implants...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Ewo_02512 and Ewo_02513 (2 items)
Embecta Medical Ii
Why: Retrospectively reported: Pen needles labeled 'For Investigational Use Only' were inadvertently distributed as commercially marketed devices.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Blood Culture Collection Venipuncture Kit
Medical Action Industries, Inc. 306
Why: Blood culture convenience kits contain a component subject to a drug recall that due to an an open or incomplete seal on the packaging of the applicator may compromise the component's sterile barrier and if used may...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Boston Scientific Corporation Stonesmart Connect Console Contents:
Boston Scientific
Why: A subset of power adapters used with the connect console may exhibit higher-than-expected resistance in the electrical grounding path. As a result, the power adaptor may fail electrical safety testing during...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Aisys and Aisys Cs2 and 2 more (4 items)
Datex-Ohmeda
Why: Anesthesia Delivery Systems containing certain electronic gas mixer assemblies can automatically transition to Alternate O2 control. In Alternate O2 control, the system delivers 100% O2 to the breathing system enabling...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Convenience Kits Anesthesia Pain Pk League Dynj67925a and Convenience Kits Minor Pack Dynj58421a Springhill Minor Pack Dynj40734f and 2 more (4 items)
Medline Industries
Why: Kits may exhibit open seals in sterile pouch packaging. Open seal may compromise product sterility. If not detected prior to use, issue may lead to contamination of sterile field or patient infection if product is used.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Device recall, ongoing
Captus
Mirion Technologies (Capintec)
Why: Potential for failure of the tension bolt which would allow the spring arm to unexpectedly fall to its lowest position, which is approximately 25 inches (63.5 cm) from the ground.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Chlorthalidone Tablets
Inventia Healthcare Limited
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 16, 2026
Drug recall, ongoing
Povidone Iodine
Imprimisrx Nj, sold nationwide
Why: Subpotent Drug
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Device recall, ongoing
Bd Alaris Pump Infusion Sets 10561554*
Bd Switzerland Sarl
Why: Due to discrepancies in specific attributes in the performance data for infusion sets, which may lead to inappropriate pump performance.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Food recall, ongoing
Diced Jalapenos. Ingredients: Jalapeno Pepper. Net Wt: and Rice & Bean Burrito. Ingredients: Rice and 21 more (25 items)
Taylor Fresh Foods
Why: Potential contamination with Salmonella.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Device recall, ongoing
Centricity Enterprise Archive V2 and Enterprise Archive V8 and 4 more (6 items)
Ge Healthcare
Why: Under certain conditions historical imaging data migrated from a legacy system may become incorrectly associated with a different patient. If this occurs, studies or images may be displayed under the wrong patient...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Biologic recall, ongoing
Red Blood Cells
the American National Red Cross
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Biologic recall, ongoing
Pooled Cryoprecipitated Ahf
the American National Red Cross
Why: Pooled Cryoprecipitated AHF, collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Biologic recall, ongoing
Red Blood Cells
American Natl. Red Cross-Greater Chesapeake & Potomac Region
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who provided travel history to a malaria endemic area, but was not assessed for residency, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Biologic recall, ongoing
Apheresis Pf24rt24 Plasma
American National Red Cross Blood Services Sw Region
Why: Apheresis PF24RT24 Plasma, collected in a manner that compromises the sterility of the collection system, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Biologic recall, ongoing
Red Blood Cells
Innovative Blood Resources
Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion, was distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Device recall, ongoing
Happiest Baby (2 items)
Happiest Baby
Why: Extra small (ES) and Extra-large (XL) infant sleep sacks have not been reviewed for safety and effectiveness by the FDA.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Device recall, ongoing
Noxboxi Nitric Oxide Delivery System.
Noxbox
Why: Potential for oxygen tubing leaks due to failure of the tubing or tubing connection, which may lead to oxygen desaturation.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Device recall, ongoing
Sunmed Tracheal Tube
Well Lead Medical Co.
Why: The 6Fr suction catheter could not pass through the samples smoothly.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Device recall, ongoing
Gm Helix Implant
Straumann USA
Why: There is a discrepancy between the product identification on the packaging and the dimensions of the implant contained inside.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Device recall, ongoing
Rt Montecarlo
Ptw Freiburg
Why: When a bolus is included in a treatment plan and sent for secondary dose calculation, the software accounts for it but does not display this clearly, which may lead users to incorrectly omit the bolus during treatment...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Drug recall, ongoing
Nystatin Cream
Sun Pharmaceutical Industries
Why: Failed Stability Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Drug recall, ongoing
Phytonadione Injectable Emulsion
Amneal Pharmaceuticals of New York
Why: Failed Impurities/Degradation Specifications
Not Yet Classified
The FDA record, with lot numbers (opens in a new tab) -
Sept. 15, 2026
Food recall, ongoing
Martina Brand Fresh Whole Mangoes
Panorama Produce Sales
Why: Product may be contaminated with Salmonella
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 14, 2026
Device recall, ongoing
Medline Convenience Kits: 1) Kit Anesthesia L&D A- Line Set and Medline Convenience Kits: 1) Open Heart Adult and 5 more (7 items)
Medline Industries
Why: The kits contain certain lots of sterile applicators which may contain fungal contamination that may occur under certain environmental conditions, allowing the growth of Aspergillus penicillioides. Contamination of skin...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 14, 2026
Food recall, ongoing
Everything Sprouts and Calco Branded Alfalfa Sprouts and Everything Sprouts Zesty Garlic Mix and 2 more (4 items)
Everything Sprouts
Why: Sprouts may be contaminated with STEC E. coli and/or Salmonella.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 14, 2026
Drug recall, ongoing
Fluphenazine HCL Elixir (6 products)
Safecor Health
Why: Failed Stability Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 14, 2026
Biologic recall, ongoing
Apheresis Platelets
Lifeshare Blood Center
Why: Apheresis Platelets, Leukocytes Reduced, with a platelet count higher than was acceptable, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 14, 2026
Biologic recall, ongoing
Plasma Frozen
New York Blood Center Enterprises
Why: Plasma Frozen, collected in an expired collection kit, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 14, 2026
Biologic recall, ongoing
Red Blood Cells
New York Blood Center Enterprises
Why: Red Blood Cells, Leukocytes Reduced, Irradiated, collected in an expired collection kit, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 14, 2026
Biologic recall, ongoing
Red Blood Cells
New York Blood Center Enterprises
Why: Red Blood Cells, Leukocytes Reduced, collected in an expired collection kit, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 14, 2026
Biologic recall, ongoing
Liquid Plasma
New York Blood Center Enterprises
Why: Liquid Plasma, collected in an expired collection kit, was distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Drug recall, ongoing
Thyroid Tablets
Vitruvias Therapeutics
Why: Superpotent Drug
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Device recall, ongoing
Statstrip Glucose Hospital Meter System. Model No: and Statstrip Glucose and B- Ketone Meter. Model No: (5 items)
Nova Biomedical
Why: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID)...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Device recall, ongoing
Power-Trialysis Short-Term Straight Dialysis Catheter and Duoglide Short-Term Straight Dialysis Catheter (2 items)
Bard Access Systems
Why: Kits contain 0.9% Sodium Chloride ampules, recalled by the supplier, that have potentially compromised sterility. If ampules are used, this could lead to systemic infection, inflammatory responses, sepsis, thrombosis...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Device recall, ongoing
Plum Administration Sets and IV Sets with Drip Chambers (5 items)
Icu Medical
Why: Intravascular administration tubing set drip chambers may have black specks potentially due to the plastic molding process leaving discolored polyvinyl chloride (PVC) material within the drip chamber wall. The presence...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Food recall, ongoing
Foods Alive Organic Moringa Leaf Powder
Foods Alive
Why: Potential Salmonella contamination
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Device recall, ongoing
IV Non-Dedicated Gravity Administration Sets with Drip Chambers and Oncology Sets with Drip Chambers (3 items)
Icu Medical
Why: Intravascular administration tubing set drip chambers may have black specks potentially due to the plastic molding process leaving discolored polyvinyl chloride (PVC) material within the drip chamber wall that does not...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Device recall, ongoing
Philips Patient Information Center Ix Ref:866389 and Philips Pic Ix Essentials Ref:867093 (2 items)
Philips North America
Why: Due to software malfunction, patient information system may freeze and become unresponsive.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Device recall, ongoing
Medline Convenience Kit: Open Heart A Pack
Medline Industries
Why: The kits contain a Retrograde Coronary Sinus Perfusion (RCSP) cannulae that has the potential for a sterile barrier breach. Sterility of the product cannot be assured. If a compromised pouch seal is not identified prior...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Device recall, ongoing
Carescape Central Station Cscs V3 Mas800 Desktop Part Number
Ge Medical Systems Information Technologies
Why: Device may not resume patient monitoring for at least 3 minutes following system restart. Issue can lead to potential delay in recognition of clinically significant events.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Device recall, ongoing
Percutaneous Insertion Kit (3 items)
Maquet Cardiopulmonary Gmbh
Why: The packaging may not consistently maintain sterile barrier integrity.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Device recall, ongoing
Medrad¿ Stellant Flex Syringe Kit Used with Stellant Flex Ct Injection System
Bayer Medical Care
Why: Some devices may not have been properly sterilized due to a manufacturing sterilization issue.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 11, 2026
Drug recall, ongoing
Lidocaine Ointment USP
Sun Pharma /Taro
Why: Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 10, 2026
Drug recall, ongoing
0.9% Sodium Chloride Injection
B Braun Medical
Why: Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Clindamycin Phosphate and Vasopressin in 0.9% Sodium Chloride and 8 more (17 products)
Baxter Healthcare, sold nationwide
Why: CGMP Deviations
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Trazodone Hydrochloride
Teva Pharmaceuticals USA, sold nationwide
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Sodium Chloride
Baxter Healthcare
Why: Presence of particulate matter: Particulates identified as fiberglass
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Glutathione
Optimal Balance Pharmacy, sold nationwide
Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Trokendi XR
Supernus Pharmaceuticals, sold nationwide
Why: Failed dissolution specifications.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Medline Convenience Kits: (16 items)
Medline Industries, sold nationwide
Why: The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Medline Convenience Kits Containing Bd Chloraprep Clear - (13 items)
Medline Industries, sold nationwide
Why: Convenience kits contain BD ChloraPrep Clear - 1mL Applicators from specific lots that were recalled by the manufacturer because they may have an open or incomplete seal on the applicator packaging. Use of potentially...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Chlorhexidine Gluconate
Sage Products, sold nationwide
Why: Cross Contamination with Other Products
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Healon Endocoat Pro
Johnson & Johnson Surgical Vision, sold nationwide
Why: Surgical instructions sent for viscoelastic products used during ophthalmic viscosurgical cataract procedures including in part: If resistance is encountered during insertion, withdraw cannula and reassess the insertion...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
the One Spf (4 products)
Allies Group, sold nationwide
Why: Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Prasugrel
Mylan Pharmaceuticals, sold nationwide
Why: Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Mycophenolate Mofetil
Mylan Pharmaceuticals, sold nationwide
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Halyard Medical Convenience Kits Labeled As: and 1) Neuro (3 items)
Avid Medical, sold nationwide
Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Presource Packs Containing Cliniclean Pericare Wipes Within Bd Urinary Catheter (12 items)
Cardinal Health 200, sold nationwide
Why: The Urinary Catheter Trays contain CliniClean Pericare Wipes which may potentially be contaminated with a lubricant used during the manufacturing process. If a contaminated wipe is used on a patient, localized skin...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
5008x Hd/Hdf with Twister Blood Tubing Set Part Number and 5008x Standard Hd Pre-Flush Standard Blood Tubing Set Part Number and 2 more (4 items)
Fresenius Medical Care Renal Therapies Group, sold nationwide
Why: Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Granuflo Dry Acid Concentrate: Product Numbers: and Naturalyte and 1 more (3 items)
Fresenius Medical Care Renal Therapies Group, sold nationwide
Why: Complaints of blue-green discoloration in product
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Baxter Novum Iq Syringe Pump (2 items)
Baxter Healthcare, sold nationwide
Why: A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Discofix Four Way Stopcock
B Braun Medical, sold nationwide
Why: Specific lots of Discofix Stopcock Sets recalled due to an incorrect expiration date printed on the carton shipper label.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Doxylamine Succinate and Pyridoxine Hydrochloride
Bionpharma, sold nationwide
Why: Presence of Foreign Tablets/Capsules
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Prasugrel
Golden State Medical Supply, sold nationwide
Why: Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Sta Staclot Protein S
Diagnostica Stago, sold nationwide
Why: A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Lux-Dx (3 items)
Boston Scientific, sold nationwide
Why: There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Velys Enabling Tech Robotic-Assist Station Ref:
Medos International Sarl, sold nationwide
Why: Software issue within robotic controller which may cause unintended movement of the robotic arm during bone preparation or instrument positioning.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Food recall, ongoing
Alfalfa
International Sprout Holdings
Why: Potential E. coli and Salmonella contamination
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Buprenorphine
American Health Packaging, sold nationwide
Why: Labeling: Label Mix-up
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Broadway Joe'S Pain Cream (2 products)
Lexia
Why: CGMP Deviations: Potential contamination of raw material
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Device recall, ongoing
Philips Brilliance Ct and Philips Ingenuity Ct Product Codes: Ingenuity Ct Upgrades and 2 more (4 items)
Philips North America
Why: Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 9, 2026
Drug recall, ongoing
Elapegademase-Lvlr
Chiesi USA
Why: Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 8, 2026
Drug recall, ongoing
Epinephrine Injection
American Regent
Why: Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 8, 2026
Biologic recall, ongoing
Apheresis Platelets
Lifesouth Community Blood Centers - Montgomery Region
Why: Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced, for which platelet yield did not meet specifications, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 8, 2026
Biologic recall, ongoing
Apheresis Platelets
the American National Red Cross South Carolina Region
Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, possibly exposed to unacceptable temperatures due to extended transit time, were distributed.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 8, 2026
Biologic recall, ongoing
Red Blood Cells
the American National Red Cross
Why: Red Blood Cells, Leukocytes Reduced, collected from donors whose arm inspections were not properly performed, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 8, 2026
Biologic recall, ongoing
Red Blood Cells
the American National Red Cross
Why: Red Blood Cells, Leukocytes Reduced, Irradiated, collected from donors whose arm inspections were not properly performed, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 8, 2026
Biologic recall, ongoing
Pf24 Plasma
the American National Red Cross
Why: PF24 Plasma, collected from donors whose arm inspections were not properly performed, were distributed.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Levothyroxine Sodium (12 products)
Accord Healthcare, sold nationwide
Why: Subpotent Drug
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride
B Braun Medical, sold nationwide
Why: Presence of Particulate matter.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Tocilizumab-Aazg
Fresenius Kabi USA, sold nationwide
Why: Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Zicam
Church & Dwight Co., sold nationwide
Why: CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Ibuprofen
Safecor Health
Why: Cross Contamination with Other Products
Not Yet Classified
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Medline Breathing Circuits Labeled As: and Medline Hudson Rci (3 items)
Medline Industries, sold nationwide
Why: Neonatal and infant heated wire breathing circuits may experience sporadic failure. The heated wire connector (pigtail) at the humidifier may exhibit discoloration, melting, smoke, burning odor, or other signs of...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Onli
Hollister Ulc, sold nationwide
Why: Hollister has identified that select lots of the catheters identified in the above table may exhibit a protrusion caused by a manufacturing defect which might lead to genitourinary trauma or bleeding.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Ramipril
Hikma Pharmaceuticals USA, sold nationwide
Why: Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Repository Corticotropin
Mallinckrodt Hospital Products, sold nationwide
Why: Presence of particulate matter: glass and stopper piece
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Medline Convenience Kits Labeled As: and Medline Convenience Kits Labeled As: Ltp Cds-Lf and 1 more (11 items)
Medline Industries, sold nationwide
Why: Kits contain a potentially contaminated component which were recalled by the manufacturer
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Halyard Total Joint Model/Catalog Number: Msbm036-03 and Davinci Trucustom Bundle Containing Tray Foley (7 items)
Avid Medical, sold nationwide
Why: Labeling Deficiency: The medical kit labeling fails to identify that the statlock component contains natural rubber latex.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Clobetasol Propionate
Lupin Pharmaceuticals, sold nationwide
Why: Failed content uniformity specifications.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Drug recall, ongoing
Paxil Cr
Apotex, sold nationwide
Why: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Ort200 and Ort300 (2 items)
Imris Imaging, sold nationwide
Why: The linear actuator and rotational lock mechanism components may experience a mechanical failure that prevents the system from transitioning between locked and unlocked state. This may pose a risk of injury to the...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Powerseal
Olympus Corporation of the Americas, sold nationwide
Why: Potential labeling deficiency in which an outer shelf box is incorrectly labeled as a 37-cm device.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Fresenius Medical Care
Fresenius Medical Care Renal Therapies Group, sold nationwide
Why: Fresenius Medical Care Renal Therapies Group, LLC (FMCRTG) has received complaints regarding flow-, no water-, or temperature-related alarms with the 2008T¿ BlueStar Hemodialysis machines.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Merge Pacs and Merge Orthopacs
Merge Healthcare, sold nationwide
Why: Software issue may cause measurements to be displayed inaccurately.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Alphenix Models Infx-8000c Infx-8000f Infx-8000v This Device Is A Digital
Canon Medical System, USA, sold nationwide
Why: Due to the fixing screws of ceiling movement gear in ceiling suspended arm that are part of the X-ray interventional systems may become loose.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Medline Medical Convenience Kits (4 items)
Medline Industries, sold nationwide
Why: Specific item(s) and lot(s) of Medline convenience kits containing Pilling Wecksorb Neurosponges and Neurosponge Strips are being recalled due to potential out-of-specification levels of endotoxin of the neurosponges.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
American Contract System Convenience Kit and American Contract System Convenience Kits (4 items)
American Contract Systems, sold nationwide
Why: The Convenience Kits contain Medline's Red Rubber Intermittent Catheters (8Fr-22 Fr) and Red Rubber Intermittent Catheter Trays. Medline Industries, LP has identified representative samples did not meet applicable...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Medline Medical Convenience Kit Labeled As: Trach Tube Kit
Medline Industries, sold nationwide
Why: Component labeling discrepancy
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Midmark Digital Ecg Hd+12 and Midmark Iqecg Digital Ecg (2 items)
Midmark, sold nationwide
Why: A communication anomoly may result in incorrect electrocardiogram waveforms of a patient and an inaccurate beats-per-minute calculation.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Structur and Grandio Universal Nano-Hybrid Restorative Material - Capsules (2 items)
Henry Schein, sold nationwide
Why: Specific lots were distributed in the US with incorrect packaging and Instructions for Use (IFU) from the U.S. FDA-cleared device.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Conmed Linvatec Genesys Crossft Suture Anchor with Disposable Driver Ref# Cfbc
Conmed, sold nationwide
Why: Suture anchor may contain incorrect patient implant card which may result in incorrect device identification and traceability.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Healthmark Prochek-Ii and Healthmark Prochek-W Protein Test for Robotic Arms (2 items)
Healthmark Industries Co., sold nationwide
Why: Test manufactured with an expired ingredient which may present as either a false negative or positive.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Fujifilm Synapse Pacs Software V7.4.310
Fujifilm Healthcare Americas, sold nationwide
Why: Software issue may cause the ruler measurement to be inaccurate.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Philips Incisive Ct with Software V4.5&V5.0
Philips Healthcare (Suzhou) Co., sold nationwide
Why: Potential of failing to trigger clinical scan during Bolus Tracking.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Sept. 2, 2026
Device recall, ongoing
Portrait Core Services Software V1.0.5 and Portrait Compute and Core Services V1.2 and 2 more (4 items)
Ge Medical Systems Information Technologies
Why: Software issue may result in a loss of patient monitoring at the Hub and Central Viewer. In addition, all alarm settings could be reset to factory defaults following the update and will not follow the alarm settings...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Cyanocobalamin and Trace Elements Injection 4 and 7 more (12 products)
American Regent, sold nationwide
Why: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Morphine Sulfate
Fresenius Kabi USA, sold nationwide
Why: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Boston Scientific Enroute Transcarotid Neuroprotection System Plus and Boston Scientific Enroute Transcarotid Neuroprotection System (2 items)
Boston Scientific, sold nationwide
Why: Potential for arterial sheath tip separation or partial tip separation during use.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Bmc/Reacthealth Luna G3 Apap Ref Lg
Bmc Medical Co.
Why: Retroactive reporting for 2024 rework conducted at the 3B/React Health warehouse
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Bd Needle Kit for Powered Driver
Bard Access Systems
Why: After placement of intraosseous (IO) needle sets, used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, users may experience difficulty/inability to remove...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Overstitch Suture Cinch and Suture Cinch Long (2 items)
Boston Scientific, sold nationwide
Why: Device may fail to deploy the cinch implant and/or fail to cut the suture as intended.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Esteem Body Soft Convex Urostomy Pouch Model/Catalog Numbers:
Convatec, sold nationwide
Why: Urostomy Pouches may leak from cap during use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Pemetrexed Disodium (2 products)
Shilpa Medicare Limited, sold nationwide
Why: Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Cemiplimab-Rwlc
Regeneron Pharmaceuticals, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
One-Piece Guedel Airway (2 items)
Intersurgical, sold nationwide
Why: Devices could potentially be occluded or partially occluded.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Carbamazepine
Golden State Medical Supply, sold nationwide
Why: CGMP deviations: tablets with black specks.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Acamprosate Calcium Enteric-Coated
Mylan Pharmaceuticals, sold nationwide
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Drug recall, ongoing
Carbamazepine Tablets
Sun Pharmaceutical Industries, sold nationwide
Why: CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Halyard Lavh Pack
Avid Medical, sold nationwide
Why: The kit component was subjected to EO sterilization, contrary to the manufacturer recommendation, which may have led to the component leaking in a kit.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Beckman Coulter and Syva Emit (2 items)
Siemens Healthcare Diagnostics, sold nationwide
Why: Due to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Blanketrol Ii Model and Blanketrol Iii and 1 more (3 items)
Gentherm Medical, sold nationwide
Why: Overheating of the 115V CPU board may cause the device to shut down.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Veritas Standard Glenoid Baseplate
Restor3d, sold nationwide
Why: Due to incorrect machining of peripheral screw hole resulting in potential for improper engagement of the peripheral screws.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Paragonix Technologies Inc. Kidneyvault Portable Renal Perfusion System Ref# Pr
Paragonix Technologies, sold nationwide
Why: Due to a firmware defect, the portable organ transfer device datalogger may lose its configuration, resulting in a blank screen and loss of displayed preservation parameters.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Td Navio Midi Speech Generating Device Model/Catalog Number: and Td Navio Maxi Speech Generating Device Model/Catalog Number: (2 items)
Tobii Dynavox, sold nationwide
Why: Under certain conditions, the battery mounting tabs may become damaged, allowing the battery to move within the device enclosure, potentially leading to an internal short circuit. This may cause localized heating and...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Hamilton Microlab Star Liquid Handler
Foundation Medicine, sold nationwide
Why: Software issue that can cause an increase in spontaneous software closures.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Cardiac Workstation (2 items)
Philips North America, sold nationwide
Why: Device will intermittently provide inaccurate data related to native heart rate.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Siemens Healthineers Immulite (2 items)
Siemens Healthcare Diagnostics Products, sold nationwide
Why: Syphilis Screen assay may contain a negative patient bias resulting in low reactive patient results being reported as nonreactive.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Endoflip System That Includes: Endoflip
Covidien, sold nationwide
Why: The system's 24-hour usage limit results in catheters incorrectly flagged as expired, making them unavailable for clinical procedures.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Beckman Coulter Dxc (2 items)
Beckman Coulter, sold nationwide
Why: a software defect in which the Parameter Package (PP) import logic overwrites all predefined calculated test rules, including those previously modified by the user, upon import of a new Parameter Package version. As a...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Fort Defiance Industries
Fort Defiance Industries, sold nationwide
Why: The Automated Field Steam Sterilizer's water recovery system 120V Amphenol connector may experience an intermittent loss of ground continuity, which could result in an unreliable fault current return path.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Arrow-Lok Implant
Arrowhead De, sold nationwide
Why: Implant did not undergo required gamma radiation dose audit. A potential reduction in sterility assurance could lead to patient infection.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Getinge Y Sensor Module
Maquet Critical Care Ab, sold nationwide
Why: The module did not undergo electrical safety tests and functional tests during production.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
American Contract Systems Medical Procedure Kits and Trays Labeled As: (2 items)
American Contract Systems
Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Arvis Surgical Navigation System Gen
Kico Knee Innovation
Why: Due to an internal sensor issue, image displayed with eyepiece may appear tilted relative to the eyepiece housing
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Minimed (3 items)
Medtronic Minimed
Why: Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Lago X and Ami Htx (2 items)
Spectral Instruments
Why: Momentary absence of On-Screen "X-Ray On" banner during run readiness check.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Dentsply Sirona Capsule Mixer Model No.
Sdi Limited
Why: Potential for electrical discharge from unit when unplugged.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 26, 2026
Device recall, ongoing
Custom Made Device Implant (2 items)
Paragon 28, sold nationwide
Why: Device was recalled due to an elevated oxygen level in excess of the allowable limit. Elevated oxygen levels may contribute to reduced material ductility.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Semaglutide (11 products)
Apollo Care, sold nationwide
Why: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Valsartan
Novartis Pharmaceuticals, sold nationwide
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Cefazolin in Dextrose
Baxter Healthcare, sold nationwide
Why: Presence of Particulate Matter
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Baxter Duo-Vent Solution Set and Male Luer Lock Adapter
Baxter Healthcare, sold nationwide
Why: Baxter received customer reports of air bubbles in the drip chamber and tubing when a pressure cuff is in use or when the tubing is flushed at the fully open position.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Glutathione
Victory Medical Center Pharmacy, sold nationwide
Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Ioversol
Liebel-Flarsheim Company, sold nationwide
Why: Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Cardinal Health Presource Kits: (8 items)
Cardinal Health 200, sold nationwide
Why: Procedure kits contain MEDICOM Ritmed Neurological Sponges that were recalled due to unexpected variability in endotoxin levels.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
V-Loc and Surgipro Ii S8698gx Surgipro Ii Bl and 2 more (5 items)
Covidien, sold nationwide
Why: Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Kian Pee Wan Capsules
Buy-Herbal
Why: Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Medline Micro-Kill Bleach Germicidal Bleach Wipes (4 items)
Medline Industries, sold nationwide
Why: Medline Micro-Kill Bleach Germicidal Bleach Wipes may exhibit a reduction in bleach concentration to levels below specification prior to the end of the labeled 12-month shelf life. Reduced bleach concentration may...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Sodium Chloride Injection
Spectra Medical Devices
Why: Manufacturing firm, Huons, was cited for issues regarding product quality and sterility assurance. If the product sterility is compromised, patients may be exposed to microorganisms, endotoxins, or foreign matter. This...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Boston Scientific Enhance Transcarotid/Peripheral Access Kit Ref: SR-4f21g7d-Mp
Galt Medical, sold nationwide
Why: Black depth markings may detach from the outer sheath of the coaxial dilator introducer component of transcarotid-peripheral access kits.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Obp Medical
Obp Medical, sold nationwide
Why: There is a potential for vaginal speculums to contain a burr on the proximal plastic blade, which may introduce a sharp edge in the contact regions for both the patient and the healthcare provider.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Sildenafil Citrate USP and Tadalafil USP (5 products)
Shoolin Pharma Chem L, sold nationwide
Why: CGMP Deviations:Noted during FDA inspection
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Clear Eyes Maximum Itchy Eye Relief
Prestige Brands Holdings, sold nationwide
Why: Lack of assurance of sterility. The recall is due to potential contamination
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Drug recall, ongoing
Clindamycin Palmitate Hydrochloride
Heritage Pharmaceuticals, sold nationwide
Why: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Gore Viabil Short Wire Biliary Endoprosthesis (2 items)
W L Gore & Associates, sold nationwide
Why: 10 mm diameter x 7 cm with transmural drainage holes (VSWVH1006) incorrectly labeled as 10 mm diameter x 10 cm length devices without transmural drainage holes (VSWVN1010).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Bobby Balloon Guide Catheter Ref: Bob-895-Cn Bob-895-Emea Bob-895-Emea-Al B
Microvention, sold nationwide
Why: Due to an increase rate of balloon pinhole defects.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Allura Xper Fd. Model Numbers:
Philips Medical Systems Nederland B.V., sold nationwide
Why: Firmware issue potentially leading to loss of geometry movements.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Glidesheath Slender A-Kit
Terumo Medical, sold nationwide
Why: Product was packaged with the 0.025 guidewire instead of the 0.021 guidewire.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Navify Digital Pathology
Ventana Medical Systems, sold nationwide
Why: Due to complaints received for the Image Management System regarding image/metadata discrepancy with the Viewer window
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Thermo Fisher Diagnostics Neisseria Meningitidis Gp C
Remel Europe, sold nationwide
Why: Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Erbecryo
Erbe USA, sold nationwide
Why: A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he gas inlet and the connector resulting in CO2 leaking into the return path, leading to excessive...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Straumann Bone Level Tapered
Straumann USA, sold nationwide
Why: Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim may inadvertently contain implants that are 12mm in length instead of 14mm as the labeling would suggest.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Xhibit Central Station
Spacelabs Healthcare, sold nationwide
Why: Due to off-the-shelf display port component that has audio/video failures
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
60 in Non-Dehp Minibore Extension Set Res Me2010 Udi-Di Code:
Bd Switzerland Sarl
Why: Products may not have received adequate sterilization processing.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Gm Helix Implant
Straumann USA, sold nationwide
Why: There may be a mismatch between the implant contained inside the packaging and the information described on the outer carton label. If the the incorrect implant is installed, the issue could cause bone compression or...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Biofire Respiratory Panel
Biofire Diagnostics, sold nationwide
Why: Due to increase in false negative results
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Philips Azurion Rystem
Philips Medical Systems Nederland B.V.
Why: Two software related issues affecting Azurion R2.2.10 Systems: 1) Potential image quality degradation that may lead to delay of therapy, procedural complications and/or inappropriate treatment and 2) Potential loss of...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Philips Azurion
Philips Medical Systems Nederland B.V.
Why: Two software related issues: 1) Potential image quality degradation that may lead to delay of therapy, procedural complications and/or inappropriate treatment and 2) Potential loss of geometry movements that may lead to...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Endo-Model
Waldemar Link Gmbh & Co. Kg (Mfg Site)
Why: The affected Endo-Model replacement set for a Rotating Hinge tibial plateau incorrectly contains a Pure Hinge plateau. The incorrect plateau could lead to a prolonged or modified surgery as the plateau cannot be...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 19, 2026
Device recall, ongoing
Pronephro Aki
Bioporto Diagnostics A/S
Why: The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in intended users.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Halyard Convenience Kits Containing Recalled Medline Namic Angiographic Star Off (3 items)
Avid Medical, sold nationwide
Why: Affected kits contain Medline Namic Angiographic Star Off Handle Manifolds, which were recalled by the manufacturer due to presence of particulates within fluid path of the Manifolds. Particulate within the fluid path...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Drug recall, ongoing
Cyclophosphamide for Injection (2 products)
Sunny Pharmtech, sold nationwide
Why: Presence of Particulate Matter; identified as stainless steel
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Stryker Ahto Dual Spike Tube Set Packaging and Stryker Ahto Tube Set Packaging and 2 more (5 items)
Stryker, sold nationwide
Why: There has been an increased amount in reported complaints consistently describing leaking from the handpiece during use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Q6 Edge and Quantum Outback and 5 more (13 items)
Pride Mobility Products, sold nationwide
Why: If the "Remind Me Later" option is selected for user reminders, reminder pop-up messages may appear while the wheelchair is in use. If this occurs while driving the wheelchair, the wheelchair may perform an unexpected...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Infinion Cx Lead Kit
Boston Scientific Neuromodulation
Why: Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Charger for the Therabody Theragun
Therabody, sold nationwide
Why: Charging cradle for the device may overheat while charging the device's removable battery pack, presenting risk of thermal event (fire). Firm has received reports alleging the product caught fire and other reports...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Radial Jaw (3 items)
Boston Scientific, sold nationwide
Why: Potential for breach in sterile barrier of device packaging.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Coaptium Connect (8 items)
Tissium Sa, sold nationwide
Why: Currently labeled shelf life of 36 months is not substantiated by real-time data. Devices will be relabeled to reflect revised shelf life of 26 months. The use of a medical device beyond its validated shelf life may...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Flow Anesthesia Machine Flow-I C20
Maquet Critical Care Ab, sold nationwide
Why: Events observed where anesthetic agent was not delivered when the vaporizer was activated. Failure to deliver the anesthetic agent may result in the patient receiving insufficient anesthesia and may lead to...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Drug recall, ongoing
Dicyclomine Hydrochloride
Aurobindo Pharma USA, sold nationwide
Why: shortfill; reports of empty capsules.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Drug recall, ongoing
Mirabegron
Zydus Pharmaceuticals (USA), sold nationwide
Why: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Femoral Valgus Adaptor and Psa Box Trial and 2 more (4 items)
United Orthopedic, sold nationwide
Why: Due to an incomplete process of the component screw by a subcontractor which prevents the properly assembling of stem trail.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Atellica Ch Urine Albumin Ref:
Siemens Healthcare Diagnostics, sold nationwide
Why: Processing of urine albumin assay on the CI analyzers may lead to the following issues: Falsely depressed Atellica CH Urea Nitrogen (UN_c) results; Falsely depressed Atellica CH Enzymatic Hemoglobin A1c (A1c_E) results...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Mc2 Portable X-Ray System
Oxos Medical, sold nationwide
Why: Due to a defective circuit board that overheats
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Forward Oral Airway Kit and Kingfisher Compact Individual First Aid Kit. Ref Number: (2 items)
Integrated Medcraft, sold nationwide
Why: Devices could potentially contain an occluded or partially occluded Guedel Airway tip.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Ge Healthcare Mac Vu360
Ge Medical Systems Information Technologies, sold nationwide
Why: Software issue issue with the MAC VU360 v3.0 system. After selecting the order refresh icon, an open preview or review screen might fail to close automatically after 2 minutes of inactivity. As a result, data from a...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Ref # D23354 and Ref # D23352 (2 items)
Beckman Coulter, sold nationwide
Why: Analyzers contain incorrect algorithms which may affect antimicrobial susceptibility test results, leading to false susceptibility classifications."
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Blom-Singer Classic Indwelling Voice Prosthesis (2 items)
Freudenberg Medical, sold nationwide
Why: Incorrect labeling- The labeled box for the Large Esophageal Flange contains a Large Esophageal and Tracheal Flange, and the labeled box for the Large Esophageal and Tracheal Flange contains a Large Esophageal Flange.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Femoral Offset Bushing (2 items)
United Orthopedic, sold nationwide
Why: Due to a design issue causing the incorrect engraved numbering on implant that could result in the incorrect orientation of the implant.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Happiest Baby
Happiest Baby, sold nationwide
Why: This recall is retroactively being reported. Refurbished bassinets failed to meet quality standards prior to distribution.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Wasplab
Copan Wasp, sold nationwide
Why: Due to a software issue within the WebApp that potentially prevents the user to overwrite the results.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
5-Plasma Bivalirudin Amr Verification Kit and 5-Plasma Bivalirudin Calibrator and 1 more (3 items)
Aniara Diagnostica, sold nationwide
Why: Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Gem Premier (2 items)
Instrumentation Laboratory, sold nationwide
Why: The active ingredient concentration in the lysing bag solution of specific GEM Premier 5000 lots did not meet established manufacturing specifications. The malfunction could result in delayed recognition and management...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Anti-Torque
Innovasis, sold nationwide
Why: Pedicle screw system intended to provide immobilization/stabilization of spinal segments as adjunct to thoracic/lumbar/sacral spine fusion may have anti-torque instrument with undersized condition which could prevent...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Nerivio Infinity. Model/Catalog Number: Fgd000100. Software Version: Fw Versio
Theranica Bioelectronics
Why: Potential for the batter to have a thermal-runway event during charging, resulting in smoke and odor.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Ge Healthcare Portrait Core Services Sw V
Ge Medical Systems Information Technologies, sold nationwide
Why: A software vulnerability may allow unauthorized persons to gain privileged access to the device, which could result in loss of patient monitoring, missed patient alarms, and/or access to Protected Health Information...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Intramedullary Bone Saw Blade Assembly Model/Catalog Number: (5 items)
Biomet
Why: Zimmer Biomet is conducting a medical device recall removal for various sizes of the Intramedullary Bone Saw Blade Assembly due to potential sterile barrier packaging damage caused by an exposed saw blade.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Munevo Drive and Munevo Drive R-Net Powered Wheelchair Hands-Free Control App
Munevo Gmbh, sold nationwide
Why: A software issue may cause the wheelchair's driving mechanism to fall out of calibration. When this occurs, the device may experience unexpected steering drift or imprecise control while driving the wheelchair. The...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Merge Pacs and Merge Orthopacs (2 items)
Merge Healthcare, sold nationwide
Why: Thumbnails from a previously opened patient study may be displayed in the Thumbnail Bar while a different patient study is currently open.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Filmarray Ngds Warrior Panel Ref Ngds-Asy-0007 Udi-Di Code:
Biofire Defense, sold nationwide
Why: Firm has identified mismatches between the outbreak strain and the reference strain used in the development of its qualitative, multiplexed, nucleic acid-based in vitro diagnostic panel test.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Hardydisk Ast Cefiderocol
Hardy Diagnostics, sold nationwide
Why: Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective antimicrobial therapy...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Dialysis Change Tray Clear Sequence
Medical Action Industries, Inc. 306, sold nationwide
Why: Convenience kits contain needle free access device that has an improper seal which may result in doming or tearing of the silicone seal.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Dash Rapid Pcr Instrument
Nuclein, sold nationwide
Why: Due to a software issue which may result in false co-infection (e.g., Positive for Flu A, when SARS-CoV-2 is present).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Philips Allura and Philips Azurion Under the Following System Descriptions and Corresponding Model and 1 more (3 items)
Philips Medical Systems Nederland B.V., sold nationwide
Why: Potential Loss of imaging functionality, loss of motorized movement, or loss of data due to unauthorized Hard Disk Drives.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Neuroguard Iep
Contego Medical, sold nationwide
Why: Carotid stent and post-dilation balloon system with integrated embolic protection system has an integrated filter, that due to a wire-to-filter-bond issue, may fail to open following sheath retraction; and if this...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Remisol Advance with Software Version
Beckman Coulter Biomedical Gmbh
Why: Due to software issues where does not handle combo assay results. The software may replace the final combo test result with one of the sub-results resulting in incorrect reporting of test outcomes.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls Smn
Siemens Healthcare Diagnostics, sold nationwide
Why: out-of-specification sodium azide concentration in Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls Lot U2. While the assay results were not impacted, the overall health risk to lab technicians due to...
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Device recall, ongoing
Syva Emit Disopyramide Assay Enzyme Immunoassay
Siemens Healthcare Diagnostics, sold nationwide
Why: Out-of-specification sodium azide concentration in Syva Emit Disopyramide Enzyme Immunoassay Calibrator Lot U1. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is...
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 12, 2026
Drug recall, ongoing
Total Parental Nutrition - Pediatric Pn Patient-Specific Tpn Bag
Central Admixture Pharmacy Services
Why: Incorrect Product Formulation
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Resmed Astral
Resmed, sold nationwide
Why: Due to a Supercapacitor electrolyte leakage on Printed Circuit Board Assembly (PCBA) may damage the charger chip, causing fail-safe state and interruption of ventilation therapy.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Stryker Hoffmann Ii Connecting Rod Micro (7 items)
Stryker Gmbh, sold nationwide
Why: Potential cracking of the Hoffmann II Carbon Connecting Rods following cleaning and sterilization.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Eopa Elongated One-Piece Arterial Cannula Dil Tip and Eopa and 1 more (6 items)
Medtronic Perfusion Systems, sold nationwide
Why: Pinhole leaks may occur in the wire-wound body during cardiopulmonary bypass. Potential risks associated with this condition may include hypovolemia, vessel laceration or perforation, hypotension, ischemia, and organ...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Pack Angiography Ncmc
Medical Action Industries, Inc. 306
Why: Cardiovascular procedure kits contain manifolds, the subject of another recall, that may have particulate within the fluid path, which has the potential to be introduced into blood circulation and become lodged within...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Ams Aligned Medical Solutions Medical Convenience Kits Labeled As: and Ams Aligned Medical Solutions Medical Convenience Kits Labeled As: Port Tray - and 4 more (8 items)
Windstone Medical Packaging, sold nationwide
Why: Windstone Medical Packaging recalled specific items and lots of AMS convenience kits containing Elevaris Lidocaine HCl injection USP. Elevaris Medical Devices Inc. recalled the Lidocaine HCl injection USP due to...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Gem Premier (6 items)
Instrumentation Laboratory, sold nationwide
Why: Potential for Bar Code Reader (BCR) wands, used with the GEM Premier 5000 and GEM Premier 7000 systems, to assign patient results to an incorrect patient ID.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Drug recall, ongoing
Azelaic Acid
Glenmark Pharmaceuticals Inc., USA, sold nationwide
Why: CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Drug recall, ongoing
Mycophenolate Mofetil
Mylan Pharmaceuticals, sold nationwide
Why: Presence of precipitate
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Drug recall, ongoing
Dorzolamide Hydrochloride and Timolol Maleate
Micro Labs USA, sold nationwide
Why: Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Ams Aligned Medical Solutions Medical Convenience Kits Labeled As: (4 items)
Windstone Medical Packaging, sold nationwide
Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Osteoballast
Isotis Orthobiologics, sold nationwide
Why: Demineralized bone matrix (DBM) in resorbable mesh indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis, were filled with approx. 4.5 cc DBM (fill for 45 ¿ 11 mm...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Power Over Fiber Base Module
Terex Utilities, sold nationwide
Why: Device not certified - no laser product report was filed with CDRH prior to distribution. Product label incorrectly states device is "Class IV", although Class 1 is appropriate for device. Improperly labeled - omitted...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Iqon Spectral Ct Iqon Spectral Ct Upgrades and Brilliance Ict Brilliance Ict Upgrades Brilliance Ict Sp Brilliance Ct and 1 more (3 items)
Philips Medical Systems, sold nationwide
Why: The clinical CT scan may not automatically trigger after the Bolus Tracking scan and may need to be triggered manually. Additional Bolus Tracking shots may occur. This may result in the clinical acquisition being...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
Permobil M3 Corpus Power Wheelchair with Heavy Duty Shock Ref:120031
Permobil, sold nationwide
Why: This recall has been reported retroactively. The power wheelchair firmware lacks a speed restriction to maintain stability when the seat lift exceeds 50 mm, which may cause the user to fall from the wheelchair or the...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
M5 Corpus Power Wheelchair Ref
Permobil, sold nationwide
Why: This recall is being reported retroactively. Power Platform firmware is missing specific drive inhibit logic. This issue may allow the chair to drive under restricted conditions, and may create an unstable condition in...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Device recall, ongoing
L-Cath Midline S/L Catheter and L-Cath Picc S/L Peripherally Inserted Central Catheter: (2 items)
Argon Medical Devices
Why: Catheters, indicated for short/long-term peripheral access to central venous system for the administration of fluids, medications, nutrients; and sampling, may experience leaking and/or cracking at the hub, which may...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Aug. 5, 2026
Drug recall, ongoing
Dabigatran Etexilate (3 products)
Ascend Laboratories, sold nationwide
Why: Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Levothyroxine Sodium (12 products)
Major Pharmaceuticals, sold nationwide
Why: Subpotent Drug
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Cetirizine Hydrochloride
Jb Chemicals and Pharmaceuticals, sold nationwide
Why: Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Amlodipine and Olmesartan Medoxomil
Ascend Laboratories, sold nationwide
Why: Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Naphazoline Hydrochloride, Polysorbate 80 and Hypromellose, Tetrahydrozoline Hydrochloride and 3 more (8 products)
Rohto-Mentholatum (Vietnam) Co., sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Trokendi XR
Supernus Pharmaceuticals, sold nationwide
Why: Failed Dissolution Specifications
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Ropivacaine Hydrochloride and Lidocaine Hydrochloride,Epinephrine Bitartrate and 2 more (5 products)
Fresenius Kabi USA, sold nationwide
Why: Presence of Particulate Matter: Hair was found in products
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Faradrive Steerable Sheath Clear and Faradrive Steerable Sheath Clear Ous and 2 more (4 items)
Boston Scientific, sold nationwide
Why: Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Medline Medical Procedure Convenience Kit Labeled As: and Medline Medical Procedure Convenience Kit Labeled As: Hip Cds-Lf (2 items)
Medline Industries
Why: The procedure kits contain ICU Medical, Inc. pain management kits containing Bupivacaine Hydrochloride in Dextrose Injection, USP, which were recalled due to quality issues that could result in drug ineffectiveness.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Medline Anterior Hip and Medline Convenience Kits Labeled As: (3 items)
Medline Industries
Why: Medline Industries, LP is issuing a recall for specific Medline kits containing B. Braun convenience kits that include Bupivacaine Hydrochloride in Dextrose Injection, USP. B. Braun Medical Inc. was notified by their...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Cyproheptadine Hydrochloride
Rising Pharma Holding, sold nationwide
Why: Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Hotline Fluid Warming Set
Icu Medical, sold nationwide
Why: ICU Medical became aware of an increased likelihood of leakage in specific Lots of L-70 HOTLINE Fluid Warming Sets due to potentially inadequate solvent application at the tubing to return connector bond.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Medline Convenience Kits Containing Bard¿ Silastic¿ Foley Catheters (9 items)
Medline Industries, sold nationwide
Why: Affected kits contain recalled Bard Silastic Foley Catheters. Catheters were recalled by manufacturer due to increased amount of raw material present on the surface of the catheter. Issue may result in the use of...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Divalproex Sodium
Bionpharma, sold nationwide
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Glycopyrrolate
Precision Dose, sold nationwide
Why: Failed Impurities/Degradation Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Halyard Standard Line Insertion Pack. Model/Catalog Number: Pvhm234-01. Conv
Avid Medical, sold nationwide
Why: Defects in the silicone seal, which may result in "doming" of the silicone seal due to improper sealing, potentially leading to fluid occlusion or leakage.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Penumbra System Red
Penumbra, sold nationwide
Why: Due to manufacturing issues, reperfusion catheters may fractures
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Safeop Patient Interface
Alphatec Spine, sold nationwide
Why: Intraoperative neuromonitoring device, due to a software issue, may experience loss or interruption of triggered electromyography (tEMG) functionality during use, displaying as system faults, loss of communication...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Minimed Go App
Medtronic Minimed, sold nationwide
Why: For MiniMed Go app version 1.0.0 and 1.1.0, when the Set day and night is turned OFF and missed dose or Correct high glucose alerts are enabled, the associated alerts will not be triggered during the nighttime. This...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Flexible Hystero-Fiberscope Kits Ref:
Karl Storz Endoscopy, sold nationwide
Why: Flexible hysteroscopes indicated for use during diagnostic and operative hysteroscopic procedures may contain an expired single use endoscopic seal for gynecology use, which could impact the assurance of sterility.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Power F2 Powered Fastening System
Ferno-Washington, sold nationwide
Why: Product may experience accelerated roller wear and potential deformation due to interference between the roller assembly and rail. In the worst-case condition, rail mechanism may become lodged during operation and...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Ventriculostomy Kit
Medtronic Neurosurgery, sold nationwide
Why: Ventriculostomy devices, used during ventriculostomy procedures to gain access to the ventricular system, may exhibit endotoxin levels that exceed the acceptable limit for devices that come into contact with...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Pipeline Flex Embolization Device with Shield Technology (2 items)
Micro Therapeutics, sold nationwide
Why: Incorrect labeling - embolization devices labeled as 3.0 mm x 20 mm implants contain 12 mm implants, and devices labeled as 3.0 mm x 12 mm implants contain 20 mm implants.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
P28 Phanton Intramedullary Nail System
Paragon 28, sold nationwide
Why: Paragon 28 received two (2) complaints were received involving breaches in the sterile barrier of the pouch packaging.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
the Intended Use Is To Be Paired with A Weapon for Aiming Purposes.
Wilcox Industries, sold nationwide
Why: Wilcox is notifying all customers who have purchased a product from the BOSS Xe family that a software enhancement to increase safety has been released and all units should be returned to implement this change.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Halyard Eye Pack. Model/Catalog Number: Lvey27 Convenience Kit.
Avid Medical, sold nationwide
Why: Incorrect concentration of Betadine solution contained within certain AVID convenience kits.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Snapshotglo Wound Imaging Device
Kent Imaging, sold nationwide
Why: The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Olympus High Flow Insufflation Unit - Uhi-4. Model Number: Uhi-4
Olympus Corporation of the Americas, sold nationwide
Why: Potential for unexpected instances where the front panel display turns off unexpectedly, and air delivery (insufflation) ceases.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Boston Scientific Therasphere
Boston Scientific, sold nationwide
Why: Software anomaly occurs when a user adds one or more vials to the cart and subsequently returns to the Activity Calculator to modify one or more input. When a user modifies an input and selects "Recalculate", the dose...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Emano Flow with Software Version V2.0.0 Gs1 Gtin Code:
Emano Metrics, sold nationwide
Why: Problem description/Reason for recall: During the period March 22, 2026, to May 29, 2026, recorded urination audio was captured at 48,000 Hz while the model was trained and validated on 44,100 Hz audio. The models...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Seaspine Polyaxial Head Ref Number:
Seaspine Orthopedics, sold nationwide
Why: Due to manufacturing error, polyaxial head may popoff from the screw intraoperatively following insertion.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
3mensio Workstation
Pie Medical Imaging B.V., sold nationwide
Why: User measurement value reported by diagnostic bioimaging software intended to measure/visualize cardiovascular structures may be larger (0.8% to 34.4%) than the actual anatomical dimension, if all the following occur...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Silent Nite Sleep Appliance
Prismatik Dentalcraft, sold nationwide
Why: Due to device not having FDA Clearance
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Olympus
Olympus Corporation of the Americas, sold nationwide
Why: Potential for the HDMI and DisplayPort (DP) connectors can become faulty resulting in image loss or image abnormalities.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Farastar Ablation Generator Eu
Boston Scientific
Why: Boston Scientific is replacing specific FARASTAR PFA generators which have a configuration that is not compatible for use with the FARAPOINT PFA catheter.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Farastar Ablation Generator Eu and Farastar Pulsed Field Ablation Generator and 1 more (3 items)
Boston Scientific
Why: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Device recall, ongoing
Medline Medical Convenience Kits Labeled As: and Medline Medical Convenience Kits Labeled As: Neuro Pack (4 items)
Medline Industries
Why: Medline Industries, LP is issuing a recall for specific Medline convenience kits containing BD PurPrep 26 mL which may be contaminated with low levels of Bacillus species.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Dabigatran Etexilate (2 products)
Ascend Laboratories, sold nationwide
Why: Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
July 29, 2026
Drug recall, ongoing
Lidocaine, Kenalog, Povidone Iodine
Asclemed USA
Why: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Abiomed Impella Cp Set and Abiomed Impella Cp Introducer Kit and 6 more (13 items)
Abiomed, sold nationwide
Why: A potential for introducer sheath leakage from under the sheath cap and along the hub score lines, identified in 14Fr and 23Fr Introducers. These manufacturing issues are not visually detectable by the user, and 14Fr or...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
General Biospy Tray and Arterial Line Kit and 4 more (6 items)
Argon Medical Devices, sold nationwide
Why: Kits containing Lidocaine HCL Injection USP 1% 10mg/mL 5mL ampules subject to another recall recalled due to not meeting release criteria for sterility.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Drug recall, ongoing
Carbamide Peroxide and Foster & Thrive (11 products)
Bell Pharmaceuticals, sold nationwide
Why: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Abiomed Ref: (3 items)
Oscor
Why: Due to manufacturing issues, there is a potential for the 14Fr and 23Fr introducer sheaths to leak from the sidearm, under the sheath cap, and along the hub score lines in the hub region.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Drug recall, ongoing
Chlorhexidine Gluconate and Isopropyl Alcohol
Carefusion 213, sold nationwide
Why: Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Drug recall, ongoing
Nystatin
Padagis US, sold nationwide
Why: Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Rapid Refill Continuous Injection System
Boston Scientific, sold nationwide
Why: Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Drug recall, ongoing
Clevipidine
Chiesi USA, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Papablic Replacement Brush Heads. Model Number: Papa317aa. and Papablic Replacement Brush Heads. Model Number: Papablic18b (2 items)
Papablic, sold nationwide
Why: Potential for brush heads to break.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Icu Medical Plum Duo Infusion Pump and Icu Medical Plum Solo Precision IV Pump (2 items)
Icu Medical, sold nationwide
Why: In a specific scenario, the pump will not decrement the Volume to be Infused (VTBI) displayed on the Delivery screen and may deliver up to twice the VTBI at the programmed rate.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Da Vinci Sp Instrument Arm Drape
Intuitive Surgical, sold nationwide
Why: Robotic-assisted surgical system arm drapes may detach from the instrument arm due to an issue involving the drape rings located at the top of the product, which may expose a section of instrument arm, which may result...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Photera (3 items)
Daavlin Distributing, sold nationwide
Why: Calibrated Output was not calculating correctly - UV Sensor GAIN being applied was incorrect - GAIN seemed to be "4/5" instead of "7" (counts were at ~1000 instead of ~5000).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Optima Xr200amx and Optima Xr220amx and 1 more (3 items)
Ge Medical Systems, sold nationwide
Why: GE HealthCare has become aware that in certain Optima XR200/220/240amx systems that have had a column replacement completed, functional testing of the safety pawl may not have been performed to confirm proper assembly....
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Olympus Ellik Evacuator Includes Glass Body and Olympus Toomey Evacuator and 1 more (4 items)
Olympus Corporation of the Americas, sold nationwide
Why: Some sterilization parameters included in the IFU may not consistently render the devices adequately sterile and therefore should no longer be used to sterilize the devices.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
St Aia-Pack Testosterone
Tosoh Bioscience, sold nationwide
Why: The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Medline Kits Containing Zimmer Biomet Mixing Bowls and Spatulas Total Knee Pa (2 items)
Medline Industries, sold nationwide
Why: Kits contain Zimmer Biomet mixing bowls and spatulas, which were recalled due to seal nonconformities which present risk of sterility breach. Health consequences from use of product include clinically insignificant...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Medtronic Bio-Medicus Adult Cannula Kit and Medtronic Dlp One-Piece Pediatric Arterial Cannula (2 items)
Medtronic Perfusion Systems, sold nationwide
Why: Medtronic received two complaints of loose foreign material confirmed as containing trace levels of blood.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
the Vasoview Hemopro
Maquet Cardiovascular, sold nationwide
Why: Getinge identified that Vasoview Hemopro 2 devices from Lot 3000547797 were exposed to an out-of-specification sterilization dose during a gamma sterilization run (Run ID 1183-28782A) performed by STERIS at its...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Rio" Ii Nasal Pillows Interface
3b Medical, sold nationwide
Why: Packaging and labeling discrepancy involving product size identification and associated Unique Device Identifier (UDI/GTIN).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 22, 2026
Device recall, ongoing
Orthofix Minirail and Orthofix Articulated Minirail Fixator Horizontal Axis Ref: M111 (4 items)
Orthofix U.S.
Why: Unilateral external fixation devices may be incorrectly labeled. Minirail M101 was labeled as M103, Minirail M103 was labeled as M101, and Minirail M122 was labeled as M111
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Drug recall, ongoing
Dimethicone
Biomed Laboratories, sold nationwide
Why: Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Olympus Single Use Distal Cover
Olympus Corporation of the Americas, sold nationwide
Why: Olympus has developed and released newly designed version of the Distal Cover (MAJ-2315) to replace previous design of the Single Use Distal Covers.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
5008x Blood Tubing Set
Fresenius Medical Care Holdings, sold nationwide
Why: Potential for Online Port Errors due to connection issues when connecting the SafeLine of the 5008X CAREset to the substitution fluid port of the 5008X CAREsystem.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Drug recall, ongoing
Gasco Isopropyl Alcohol and Drogueria San Juan Puerto Rico Isopropyl Alcohol (6 products)
Gasco Industrial, sold nationwide
Why: Subpotent drug
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Drug recall, ongoing
Pemetrexed for Injection and Bortezomib for Injection and 1 more (4 products)
Reliance Life Sciences Private Limited, sold nationwide
Why: Lack of Sterility Assurance
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Atellica Ch Enzymatic Hemoglobin A1c
Siemens Healthcare Diagnostics, sold nationwide
Why: The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Intracept Access Instruments
Boston Scientific Neuromodulation, sold nationwide
Why: Intraosseous nerve ablation system instruments may have sterile barrier breach of the outer tray seal, which may introduce a risk of sterility breach, and if breached could lead to severe infection.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Drug recall, ongoing
Methohexital Sodium
Onesource Specialty Pharma Limited, sold nationwide
Why: Failed Impurities/Degradation Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Drug recall, ongoing
Methohexital Sodium
Quva Pharma, sold nationwide
Why: Failed Impurities/Degradation Specifications
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Aquacel AG Surgical Sp Ref:
Convatec, sold nationwide
Why: Surgical dressing manufactured out of specification (greater thickness).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Gsp Neonatal Galt Kit. Product Codes:
Wallac Oy, sold nationwide
Why: Reduction in the on-board stability of the GSP GALT assay. This may increase the likelihood of run-QC failures and consequently delay the reporting of patient results.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Kl Owen Custom Orthodontic Solution
Klowen Braces, sold nationwide
Why: A product error defect may cause incorrect bracket placement.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Vesius Surgeon Console US
Cmr Surgical Limited, sold nationwide
Why: Secure Boot was mistakenly not enabled at manufacturing time, which presents a potential cybersecurity risk.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Medline Convenience Kits: (3 items)
Medline Industries, sold nationwide
Why: Convenience Kits contain Covidien Mon-a-Therm General Purpose Temperature Probes Size 9 Fr. Medtronic has issued a recall of specific production lots of the Covidien Mon-a-Therm general purpose temperature probe-size 9...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Fletcher Ct/Mr Shielded Applicator Set Product Name: Intracavitary Remote After and Brachytherapy Applicator Product Name: Advanced Gynecological Applicator Produ and 1 more (3 items)
Elekta, sold nationwide
Why: Due to safety concerns regarding the detachment of the tip of the intrauterine tube (IU tube) that may remain within a patient.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Tmini Femur Tracking Array Ref
Think Surgical, sold nationwide
Why: Due to manufacturing/design issue where the knob on the tracking array may loosen causing potential misalignment of the array.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Vitek
Biomerieux
Why: Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Omnitract Surgical Retractor System
Integra Lifesciences Corp. (Neurosciences), sold nationwide
Why: The current Omni-Tract Surgical Retractor System IFU states a dry time of 30 minutes. Integra LifeSciences has identified that the dry time needs to be extended to 90 minutes, 110 minutes, or 120 minutes depending on...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Drug recall, ongoing
Clomiphene Citrate USP Active Pharmaceutical Ingredient
Shimoga Chemicals
Why: cGMP deviations
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Minimed
Medtronic Minimed
Why: A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Empowr (2 items)
Encore Medical
Why: Due to packaging discrepancy with incorrect product size mixed up.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Levothyroxine Sodium
Accord Healthcare, sold nationwide
Why: Subpotent Drug
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Undecylenic Acid and Fungal Fusion Eradication Solution and 3 more (8 products)
Blaine Labs, sold nationwide
Why: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Omnipod and Omnipod Dash Pod. Includes the Below Model/Ref Numbers: (3 items)
Insulet, sold nationwide
Why: External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Hillrom Volara System P.Circuit Kit Ac and Hillrom Volara System P.Circuit and 2 more (4 items)
Baxter Healthcare, sold nationwide
Why: There have been reports of air and medication leakage from the nebulizer cup during therapy of Volara system patient circuits. The leakage can lead to an oxygen level drop in the patient and ineffective nebulization...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Breathing Circuit Set
Hamilton Medical AG, sold nationwide
Why: Ventilator coaxial breathing circuit may have, expiratory valve sets with membranes sticking to valve body, not detectable during pre-operative test, which will result in "exhalation obstructed " alarm, which may result...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Chlorhexidine Gluconate and Isopropyl Alcohol and Povidone Iodine and Isopropyl Alcohol (10 products)
Carefusion 213, sold nationwide
Why: Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Synjardy XR Tablets
Boehringer Ingelheim Pharmaceuticals
Why: CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Ck000495a Poly Midline Catheter and 5855240 Power-Trialysis Slim-Cath Straight Short-Term Dialysis Catheter and 12 more (14 items)
Bard Access Systems, sold nationwide
Why: Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Cre Pro Wireguided and Cre Wireguided (12 items)
Boston Scientific, sold nationwide
Why: Potential sterile breach of the pouches in which devices are packaged.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
A M S (4 items)
Windstone Medical Packaging, sold nationwide
Why: Kits contain Webcol Large Alcohol Prep Pad which were recalled by Cardinal Health following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Medtronic Harmony Delivery Catheter System
Medtronic Heart Valves Division, sold nationwide
Why: Devices containing inner shaft assemblies from specific manufacturing lots may have an increased potential for distal tip detachment from the delivery system under certain procedural or anatomical conditions due to a...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Reprocessed Electrophysiology Catheters and Ultrasound Catheters Item No.
Medline Industries, sold nationwide
Why: Expansion of RES 98277. Specific lots of reprocessed catheters may contain small particles of residual material. If devices with residual particulates on patient-contacting surfaces are used, there is a potential risk...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Prednisolone Acetate
Lupin Pharmaceuticals, sold nationwide
Why: Presence of Foreign Substance
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Medline Convenience Kits Containing Recalled Swan-Ganz Catheters Kit Germanto and Medline Convenience Kits Containing Recalled Swan-Ganz Catheters Cardiac Majo and 5 more (8 items)
Medline Industries, sold nationwide
Why: Kits contain Swan-Ganz catheters recalled by Becton Dickinson (BD). BD has received complaints of leaks/breakage involving failures of the (blue) proximal injectate lumen hub on these catheters. This has led to...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Pilling Wecksorb Neurosponges
Teleflex, sold nationwide
Why: Due to out-of-specification, or potential out-of-specification, levels of endotoxins
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Medline Convenience Kits: (15 items)
Medline Industries, sold nationwide
Why: The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identified during a recent...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Covidien Shiley Disposable Decannulation Plug Ref Ddcp Udi-Di Code:
Covidien, sold nationwide
Why: Due to product labeling incorrectly including the symbol indicating non-DEHP (Bis(2-ethylhexyl) phthalate as the product includes 30 to 35% DEHP.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Glucagon
Lupin Pharmaceuticals, sold nationwide
Why: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Cinacalcet (3 products)
Cipla USA, sold nationwide
Why: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
A.T.S¿ (2 items)
Zimmer Surgical, sold nationwide
Why: Potential sterility breach in sealing area of sterile pouch. If used, issue may result in moderate localized infection. If discovered prior to use, may result in clinically insignificant extension of surgery to find...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Lidocaine Hydrochloride and Lidocaine Hydrochloride Anhydrous (2 products)
Asclemed USA, sold nationwide
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Ustekinumab-Srlf
Accord Biopharma, sold nationwide
Why: Lack of assurance of Sterility:
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Gemcitabine
Mckesson, sold nationwide
Why: Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate
Lannett Company, sold nationwide
Why: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Gc Agar Base
Remel, sold nationwide
Why: Reduced or no recovery of some strains of Neisseria gonorrhoeae.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Raycare (2 items)
Raysearch Laboratories Ab, sold nationwide
Why: Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Radius Vsm Ecg Pre-Connected Set and Radius Vsm Disposable Nibp Cuff (2 items)
Masimo, sold nationwide
Why: Two devices recalled: 1) Electrocardiogram (ECG) electrode assembly ECG feature may incorrectly detect extreme bradycardia, tachycardia and trigger alarms on normal heart rate patients, which may distract clinicians...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Zeiss Intrabeam Spherical Applicator
Carl Zeiss Meditec AG, sold nationwide
Why: Spherical applicators (radiation therapy accessory) failed to meet manufacturing specifications.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Artis Icono Ceiling. Model Number:
Siemens Medical Solutions USA, sold nationwide
Why: Potential issue with the Display ceiling suspension (DCS Fix XL) that holds the monitor in place. Over time some screws that keep the monitor attached to the suspension may gradually loosen.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Enfit Exset Strl
Medela
Why: May contain incorrect connectors and will not attach or misconnect to ENFit connections and is thus incompatible. Issue could lead to slight delay in delivery of enteral nutritional fluids or oral medication.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Gore¿ Tag¿ Thoracic Branch Endoprosthesis Side Branch Component Catalog Numbers
W L Gore & Associates, sold nationwide
Why: Due to catheter separation
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Cyberknife Treatment Deliver System Equipped with the Xchange Robotic Collimator
Accuray Incorporated, sold nationwide
Why: In certain cases, a collimator may not fully dock, which triggers a system interlock and prevents motion from the operator console. If personnel then enter the treatment room and initiate motion using the in-room...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Adapter for Head Positioning
Baxter Healthcare, sold nationwide
Why: The Adapter for Head Positioning accessory may become loose during patient positioning and unintentionally move when used in conjunction with the side rails of the Upper Back Section H V U component on Baxter operating...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Artis Icono Floor. Model Number: and Artis Icono Biplane. Model Number: and 1 more (3 items)
Siemens Medical Solutions USA, sold nationwide
Why: Potential for loss of movement capability after adjusting the detector lift height to its maximum or minimum limits.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Cyberknife Treatment Deliver System Equipped with the Xchange Robotic Collimator
Accuray Incorporated, sold nationwide
Why: In certain cases, a collimator may not fully dock, which triggers a system interlock and prevents motion from the operator console. If personnel then enter the treatment room and initiate motion using the in-room...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Solar Gi System
Laborie Medical Technologies, sold nationwide
Why: Under extended clinical use conditions (e.g., long duration studies), moisture generated within the pneumatic circuit may accumulate inside the system's internal tubing or at the hydrophobic filter and waterproof...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Short Monobloc Stem Broaches
Medacta USA, sold nationwide
Why: Surgical instruments used during shoulder arthroplasty procedures does not progressively translate to replicate implant geometry, so the reaming guide and the stem reamer are positioned approximately 0.2 mm per size...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Intellicuff
Hamilton Medical AG, sold nationwide
Why: Due to reported complaints, the cuff device may alarm with a "Cuff System Leakage" error. As a result, the motor may pump continuously and fail to maintain the cuff pressure set by the user.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Syringe Luer Lok
Mentor Texas
Why: A single lot of expired syringes were distributed due to a distribution system control failure.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Depuy Synthes (2 items)
Depuy (Ireland)
Why: The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Device recall, ongoing
Medline
Bd Switzerland Sarl
Why: Due to engineering sample labeled "Not for Human Use" being inadvertently shipped it the U.S. market.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 8, 2026
Drug recall, ongoing
Fexofenadine Hydrochloride Tablets
Sun Pharmaceutical Industries, sold nationwide
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Chlorhexidine Gluconate and Isopropyl Alcohol (4 products)
Carefusion 213, sold nationwide
Why: Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Duloxetine D/R
Direct Rx, sold nationwide
Why: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Ivabradine and Cinacalcet Hydrochloride (5 products)
Amgen, sold nationwide
Why: Presence of Foreign Substance.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Convenience Kits Containing Select Skus of (16 items)
Medline Industries, sold nationwide
Why: Firm identified unapproved design changes to the products outside of the 510(k) cleared by the FDA. Products not initially reported in RES 98601.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Abiomed Impella Cp Set with Smartassist and Abiomed (4 items)
Abiomed, sold nationwide
Why: Potential for thrombus formation during prolonged use of the introducer.
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Medline Convenience Kits: (4 items)
Medline Industries, sold nationwide
Why: The Medline Convenience Kits contain Arrow Kits and Sets that include Lidocaine Hydrochloride Injection, USP and Bupivacaine Hydrochloride in Dextrose Injection, USP which were recalled due to quality issues identified...
Class I: could cause serious harm or death
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Lacosamide
Annora Pharma Private Limited, sold nationwide
Why: Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Povidone-Iodine 10% Topical
Elevate Oral Care, sold nationwide
Why: sub potency
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Surgify Halo (19 items)
Surgify Medical Oy, sold nationwide
Why: Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Off-Axis Comprehensive Shoulder System and Off-Axis Alliance Glenoid and 1 more (5 items)
Zimmer, sold nationwide
Why: Five complaints have been received identifying issues where the plastic guides were catching during reaming, leading to breakage.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Inzone Detachment System
Stryker Neurovascular, sold nationwide
Why: Embolization coil detachment system devices may experience premature battery drain causing devices to: 1) Not power on; 2) Power on with faint audible and visual indicators; 3) Be unable to detach a coil as intended...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Fenofibrate
Ajanta Pharma USA, sold nationwide
Why: CGMP Deviations
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Methylergonovine Maleate
the Harvard Drug Group, sold nationwide
Why: Subpotent Drug
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Perampanel
Sun Pharmaceutical Industries, sold nationwide
Why: Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Vocsn+Pro Package
Ventec Life Systems, sold nationwide
Why: Respiratory system intended to provide continuous/intermittent ventilator support, may have a damaged back-up battery supporting backup alarm function, which may result in the backup alarm not activating during loss of...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Philips Avalon Fetal Monitor (2 items)
Philips North America, sold nationwide
Why: Monitor has incorrect assembly of the speaker connector which can cause device cables to be pulled out of the housing and increase the risk of intermittent or permanent loss of speaker output.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Octopus Evolution As Tissue Stabilizer and Octopus and 1 more (3 items)
Medtronic Perfusion Systems, sold nationwide
Why: During the manufacturing process, Medtronic personnel identified an assembly issue where the tubing was incorrectly positioned. The short tube was attached to the bottom of the canister, and the long tube was attached...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Da Vinci Assy
Intuitive Surgical, sold nationwide
Why: Operative components of surgical systems potentially distributed with E-brake retainer pin, so in event of a structural column failure, the E-brake pin would prevent E-brake engagement and may result in uncontrolled...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Thuvera Laser Console. Software Version
Ipg Medical, sold nationwide
Why: Software anomaly that causes a false display of error code 5018.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Multi-Snare Set:
Pfm Medical, sold nationwide
Why: A snare catheter including luer lock, indicated for removal or manipulation of a foreign body in the vascular system, failed to meet the biocompatibility requirements for in-vitro-cytotoxicity, which if in contact with...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Ge Healthcare Aw Server
Ge Medical Systems Scs, sold nationwide
Why: GE HealthCare has become aware of a context synchronization issue in AW Server 3.2 ext. 6.5. When a user selects a patient or exam in the AW Server Web Client worklist and launches an interactive application (e.g....
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Tmj Bilateral Implants
Tmj Solutions, sold nationwide
Why: Custom temporomandibular joint implant may have contained incorrect patient-specific components that led to a poor fit of the implant, leading to a right-sided open bite.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Acumed Hexalob Screw Various Sizes: Ref Numbers: :
Acumed, sold nationwide
Why: Due to manufacturing error, hexalobe screws used with wrist fixation system may break during use.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Philips Telemetry Monitor
Philips North America, sold nationwide
Why: Potential for device reset to default "NEW_DEVICE" state, which may lead to a to loss of device configuration and the equipment label, resulting in a failure to reconnect to the PIC iX central monitoring system.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Total Parental Nutrition - Pediatric Pn Patient-Specific Tpn Bag
Central Admixture Pharmacy Services
Why: Incorrect product formulation: bag did not contain copper and famotidine per label.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Preye Vitamin See Antioxidant Preservative Free Eye Drops
Preye
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Dexcom G7 US Retail Sensor/Transmitter
Dexcom
Why: Certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process. The sensors were later sold to pharmacies and distributors by Pharmsource, LLC....
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, ongoing
Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment
Zimmer
Why: Firm received a complaint with no clinical impact in which a posterior augment was found within the distal augment package.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Drug recall, ongoing
Hydroxyzine Hydrochloride
Ani Pharmaceuticals, sold nationwide
Why: Presence of foreign substance
Class III: unlikely to cause harm
The FDA record, with lot numbers (opens in a new tab) -
July 1, 2026
Device recall, completed
Intera Oncology Intera
Boston Scientific, sold nationwide
Why: There is the potential for leakage along the drug pathway from the pump through the end of the catheter.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab)
Current drug shortages
70 drugs
| Drug | Status | Updated | Reason | Category |
|---|---|---|---|---|
| Amino Acid Injection | Current | Sept. 22, 2026 | Shortage of an inactive ingredient component | Gastroenterology |
| Atropine Sulfate Injection | Current | Sept. 22, 2026 | Discontinuation of the manufacture of the drug | Anesthesia, Neurology, Pediatric |
| Bupivacaine Hydrochloride Injection | Current | Sept. 22, 2026 | Demand increase for the drug | Anesthesia |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Current | Sept. 22, 2026 | Other | Anesthesia |
| Carboplatin Injection | Current | Sept. 22, 2026 | Other | Oncology |
| Dextrose Monohydrate 10% Injection | Current | Sept. 22, 2026 | Discontinuation of the manufacture of the drug | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Dextrose Monohydrate 5% Injection | Current | Sept. 22, 2026 | Demand increase for the drug | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Dextrose Monohydrate 50% Injection | Current | Sept. 22, 2026 | Other | Endocrinology/Metabolism, Gastroenterology, Pediatric |
| Dextrose Monohydrate 70% Injection | Current | Sept. 22, 2026 | Other | Endocrinology/Metabolism, Gastroenterology, Other, Pediatric |
| Dobutamine Hydrochloride Injection | Current | Sept. 22, 2026 | Other | Cardiovascular, Pediatric, Renal |
| Dopamine Hydrochloride Injection | Current | Sept. 22, 2026 | Other | Cardiovascular |
| Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Current | Sept. 22, 2026 | Other | Anesthesia, Pediatric |
| Etomidate Injection | Current | Sept. 22, 2026 | Demand increase for the drug | Anesthesia |
| Fentanyl Citrate Injection | Current | Sept. 22, 2026 | Demand increase for the drug | Analgesia/Addiction, Pediatric |
| Furosemide Injection | Current | Sept. 22, 2026 | Other | Cardiovascular |
| Heparin Sodium Injection | Current | Sept. 22, 2026 | Other | Hematology |
| Hydromorphone Hydrochloride Injection | Current | Sept. 22, 2026 | Other | Analgesia/Addiction |
| Ketorolac Tromethamine Injection | Current | Sept. 22, 2026 | Other | Analgesia/Addiction |
| Lidocaine Hydrochloride Injection | Current | Sept. 22, 2026 | Other | Anesthesia, Pediatric |
| Liraglutide Injection | Current | Sept. 22, 2026 | Delay in shipping of the drug | Endocrinology/Metabolism |
| Lorazepam Injection | Current | Sept. 22, 2026 | Demand increase for the drug | Neurology |
| Meperidine Hydrochloride Injection | Current | Sept. 22, 2026 | Not stated | Analgesia/Addiction |
| Methotrexate Sodium Injection | Current | Sept. 22, 2026 | Demand increase for the drug | Rheumatology, Oncology |
| Midazolam Hydrochloride Injection | Current | Sept. 22, 2026 | Demand increase for the drug | Anesthesia, Neurology |
| Morphine Sulfate Injection | Current | Sept. 22, 2026 | Other | Analgesia/Addiction |
| Promethazine Hydrochloride Injection | Current | Sept. 22, 2026 | Demand increase for the drug | Analgesia/Addiction, Gastroenterology, Other, Pulmonary/Allergy |
| Rocuronium Bromide Injection | Current | Sept. 22, 2026 | Delay in shipping of the drug | Anesthesia |
| Sodium Acetate Injection | Current | Sept. 22, 2026 | Other | Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition |
| Sodium Bicarbonate Injection | Current | Sept. 22, 2026 | Other | Endocrinology/Metabolism, Gastroenterology, Pediatric |
| Sterile Water Injection | Current | Sept. 22, 2026 | Demand increase for the drug | Other |
| Sterile Water Irrigant | Current | Sept. 22, 2026 | Demand increase for the drug | Gastroenterology, Other, Pediatric |
| Sufentanil Citrate Injection | Current | Sept. 22, 2026 | Other | Analgesia/Addiction, Pediatric |
| Clindamycin Phosphate Injection | Current | Sept. 21, 2026 | Demand increase for the drug | Anti-Infective |
| Dexmedetomidine Hydrochloride Injection | Current | Sept. 21, 2026 | Demand increase for the drug | Anesthesia |
| Methylprednisolone Acetate Injection | Current | Sept. 21, 2026 | Demand increase for the drug | Rheumatology |
| Penicillin G Benzathine Injection | Current | Sept. 21, 2026 | Other | Anti-Infective |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Current | Sept. 18, 2026 | Shortage of an active ingredient | Psychiatry |
| Azacitidine Injection | Current | Sept. 18, 2026 | Demand increase for the drug | Oncology |
| Bumetanide Injection | Current | Sept. 18, 2026 | Delay in shipping of the drug | Cardiovascular |
| Cefotaxime Sodium Powder, for Solution | Current | Sept. 18, 2026 | Demand increase for the drug | Anti-Infective, Pediatric |
| Dexamethasone Sodium Phosphate Injection | Current | Sept. 18, 2026 | Demand increase for the drug | Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology |
| Furosemide Oral Solution | Current | Sept. 18, 2026 | Shortage of an inactive ingredient component | Cardiovascular |
| Ifosfamide Injection | Current | Sept. 18, 2026 | Demand increase for the drug | Oncology, Pediatric |
| Lisdexamfetamine Dimesylate Capsule | Current | Sept. 18, 2026 | Other | Psychiatry |
| Lisdexamfetamine Dimesylate Tablet, Chewable | Current | Sept. 18, 2026 | Not stated | Psychiatry |
| Methylphenidate Hydrochloride Tablet, Extended Release | Current | Sept. 18, 2026 | Discontinuation of the manufacture of the drug | Psychiatry |
| Propranolol Hydrochloride Injection | Current | Sept. 18, 2026 | Shortage of an active ingredient | Cardiovascular |
| Remifentanil Hydrochloride Injection | Current | Sept. 18, 2026 | Demand increase for the drug | Analgesia/Addiction |
| Rifampin Injection | Current | Sept. 18, 2026 | Discontinuation of the manufacture of the drug | Anti-Infective |
| Technetium TC-99M Pyrophosphate Kit Injection | Current | Sept. 18, 2026 | Other | Medical Imaging |
| Valproate Sodium Injection | Current | Sept. 18, 2026 | Not stated | Neurology |
| Cromolyn Sodium Concentrate | Current | Sept. 17, 2026 | Other | Pulmonary/Allergy |
| Metronidazole Injection | Current | Sept. 17, 2026 | Other | Anti-Infective |
| Ropivacaine Hydrochloride Injection | Current | Sept. 17, 2026 | Demand increase for the drug | Anesthesia |
| Clonazepam Tablet | Current | Sept. 16, 2026 | Other | Neurology, Pediatric, Psychiatry |
| Conivaptan Hydrochloride Injection | Current | Sept. 16, 2026 | Delay in shipping of the drug | Cardiovascular |
| Desmopressin Acetate Spray | Current | Sept. 16, 2026 | Requirements related to complying with good manufacturing practices | Hematology |
| Streptozocin Powder, For Solution | Current | Sept. 16, 2026 | Other | Oncology |
| Flurazepam Hydrochloride Capsule | Current | Sept. 15, 2026 | Regulatory delay | Neurology, Other |
| Hydroxocobalamin Injection | Current | Sept. 15, 2026 | Other | Other |
| Quinapril Hydrochloride Tablet | Current | Sept. 15, 2026 | Requirements related to complying with good manufacturing practices | Cardiovascular |
| Quinapril/Hydrochlorothiazide Tablet | Current | Sept. 15, 2026 | Discontinuation of the manufacture of the drug | Cardiovascular |
| Rifampin Capsule | Current | Sept. 15, 2026 | Discontinuation of the manufacture of the drug | Anti-Infective |
| Riluzole Oral Suspension | Current | Sept. 15, 2026 | Requirements related to complying with good manufacturing practices | Neurology |
| Triamcinolone Hexacetonide Injection | Current | Sept. 15, 2026 | Not stated | Rheumatology |
| Methylphenidate Film, Extended Release | Current | Sept. 2, 2026 | Not stated | Psychiatry |
| Echothiophate Iodide Ophthalmic Solution | Current | Sept. 1, 2026 | Other | Ophthalmology |
| Pentostatin Injection | Current | Aug. 27, 2026 | Other | Oncology |
| Isocarboxazid Tablet | Current | Aug. 6, 2026 | Other | Psychiatry |
| Bacitracin Ophthalmic Ointment | Current | June 1, 2026 | Discontinuation of the manufacture of the drug | Anti-Infective, Ophthalmology |
Sources: openFDA recall and shortage records (opens in a new tab)